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Overview 
The portfolio has three parts. 
Part One is a systematic literature review concerning the nature and severity of the 
psychological distress experienced by carers (primarily parents) of people with Muscular 
Dystrophy. Quantitative and qualitative studies investigating distress in these carers have 
been reviewed and critically evaluated to draw conclusions and implications for clinical 
practice. 
Part Two is an empirical paper aimed at creating a cognitive profile for people suffering from 
Duchenne Muscular Dystrophy in the advanced stages of the illness. The focus of this cross-
sectional study is placed on the investigation of whether hypoventilation, inevitably seen to 
develop in this population, is related to permanent cognitive deficits in memory and/or 
executive functioning. The participants who have been identified to suffer from 
hypoventilation (N=17) are compared on measures of memory and executive functioning to a 
group of DMD participants of similar age (N=16) who have not yet developed 
hypoventilation. Other measures are also taken in the form of questionnaires to compare the 
groups on, including demographics, mood (depression and anxiety), health-related quality of 
life, sleepiness, and beliefs about sleep. 
Part Three comprises the Appendices.  
 
 
 
 
 
 
4 
 
Contents 
Page No. 
Part One: Psychological distress in carers of people with Muscular Dystrophy: A 
systematic literature review. 
Abstract 8 
Background 9 
Method 15 
Results 20 
Discussion  43 
Conclusions and Implications 47 
References 48 
 
Part Two: Cognitive profile in advanced Duchenne Muscular Dystrophy (DMD) and the 
effects of Non-invasive Positive Pressure Ventilation (NIPPV) on cognition.  
Abstract 59 
Introduction 60 
Method 65 
Results 69 
Discussion  74 
References 79 
 
Part Three: Appendices 
Appendix A – Reflective statement 83 
Appendix B – Guidelines for authors for the systematic literature review 87 
Appendix C – Guidelines for authors for the empirical paper 90 
Appendix D – Search Strategy in PsychINFO for ‗carer‘ term 97 
Appendix E – Search Strategy in PsychINFO for ‗muscular dystrophy‘ term 99 
Appendix F – Search Strategy in PsychINFO for ‗psychological distress‘ term 100 
5 
 
Appendix G – Standardized Data Extraction Sheet 102 
Appendix H – Quality Assurance Checklist: Qualitative studies 104 
Appendix I – Quality Assurance Checklist: Quantitative studies 105 
Appendix J – Quality Assessment Scores 107 
Appendix K – Instructions for recruitment 109 
Appendix L – Descriptions of the psychometric measures used 110 
Appendix M – Information sheet for main study 113 
Appendix  N – Consent form 117 
Appendix O – Ethical and R&D approval documentation 118 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
List of Tables and Figures 
Page No. 
Part One: Psychological distress in carers of people with Muscular Dystrophy: A 
systematic literature review. 
Table 1. Rolland‘s (1987) conceptualisation of the nature of psychosocial 
demands present at various stages of a range of chronic illnesses. 
13 
Table 2. Inclusion criteria and their justification. 16 
Table 3. Exclusion criteria and their justification. 17 
Table 4. Study design hierarchy (Khan et al., 2001). 17 
Table 5. Main characteristics of the studies included in the review (N=20). 21 
  
Figure 1. A flowchart of the article selection process. 18 
Part Two: Cognitive profile in advanced Duchenne Muscular Dystrophy (DMD) and the 
effects of Non-invasive Positive Pressure Ventilation (NIPPV) on cognition.  
Table 1. Psychometric measures used and the corresponding cognitive areas 
tested 
66 
Table 2. Demographic information and comparisons of DMDC and DMDV 
groups  
69 
Table 3. Mean (SD) score and statistical significance of differences between the 
DMDC and DMDV groups on ESS, DBAS, HADS, and SF-36. 
70 
Table 4. Mean (SD) and significance of differences between the DMDC and 
DMDV groups on the psychometric measures. 
71 
Table 5. Number of participants in DMDC (N=14) and DMDV (N=17) groups 
that are on or below the cut-off scores for each measure used. 
72 
 
 
 
 
 
7 
 
 
 
 
 
 
 
 
Psychological distress in carers of people with Muscular Dystrophy: A 
Systematic Literature Review
1
 
G Papadopoulou
2
, C Derbyshire
3
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
1
 This paper is written in the format ready for submission to the British Journal of Health Psychology.  Please 
see Appendix B for the Guidelines for Authors. 
2
 Correspondence to Georgia Papadopoulou, Department of Clinical Psychology, University of Hull, Hull HU6 
7RX, UK. g.papadopoulou@2007.hull.ac.uk 
3
 University of Hull, Hull, UK 
8 
 
Abstract 
Purpose Medical advances have meant people with Muscular Dystrophies are surviving 
longer and require a high level of care longer-term. Care is increasingly taken up by families, 
primarily parents, in the home. The question of the impact of providing this care on these 
individuals has   therefore become pertinent. This review aims to determine the degree and 
nature of distress experienced by carers, and consider service implications. 
Methods A systematic literature review was conducted of quantitative and qualitative 
studies investigating distress and people‘s experiences of caring for a person with Muscular 
Dystrophy. Data was extracted and analysed using descriptive (non-quantitative) analysis. 
Results The data suggest that there is a high level of distress amongst carers of people 
with MD. This distress impacts not only on psychological well-being, but also on social, 
familial, physical, and financial aspects of life. A positive aspect of caring also emerged, 
within which carers have felt enriched as they achieved a meaningful and adjusted way of 
life. 
Conclusions Distress is present in carers‘ lives, without necessarily depriving them of hope 
and enrichment. Services providing medical care for these patients need to include carer 
distress in their care plans, and provide psychological, as well as practical support and advice, 
particularly at times of crisis. 
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Background 
Carers of children with Muscular Dystrophy (MD) are part of a wider group of carers, who 
take on the often life-long task of caring for their chronically-ill child. This review begins 
with an overview of the literature on carers of chronically-ill children in order to set the 
context, and  is followed by a brief outline of MD along with a summary of the literature 
involving carers of people with MD, leading onto the aims of this review. 
Caring for Chronically-Ill Children 
Many studies look at the physical, emotional, and social impact of caring for a chronically-ill 
child (e.g. McGarth, 2001; Carnevale et al., 2006). Hatzmann et al. (2009) noted that 
―caregiving demands can be extensive, and may lead to adverse psychosocial consequences 
for parents‖ (p.2). 
Boyer (1986) explains that when parents find out that their child is not healthy they face both 
practical and emotional turmoil. Financial pressures can arise due to the costs of treatment or 
the caregiver having to give up their job. Prolonged family stress can lead to physical and 
emotional symptoms (Burton, 1975), such as distress, anxiety, sleep disturbance, and tensions 
in family relationships (Colville et al., 1996; Ievers & Drotar, 1997; Wase et al., 1998). The 
impact on familial relationships often leads to anger, guilt, blame, and denial since caring for 
the affected child takes time away from other family responsibilities or from the caregivers‘ 
personal time (Boyer, 1986). These tense familial relationships augment the emotional and 
practical difficulties, which are likely to worsen between transitional stages of the life cycle 
(Erikson, 1968).  
McGrath (2001) found that carers of children with a life-limiting condition request support 
for practical and emotional issues. However, these parents reported minimal or no support 
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from extended family, friends, or support groups whilst they were trying to cope with 
physical, emotional, and social demands from their child‘s condition.  
Carnevale et al. (2006) looked at family experiences of caring for a child using ventilator 
assistance. Their study replicated many of the findings around carer distress including 
emotional strain, feelings of isolation, and a need for stability and normalisation within the 
family. Nevertheless, the authors found experiences of distress as well as of enrichment and 
reward. The emerging overarching theme was that ‗the struggle is worthwhile‘ (p.54) despite 
the impact on the carer‘s physical (Patterson et al., 1992) and mental health (Leonard et al., 
1993), financial strain, reduced social interactions (Cohen, 1999), a poorer family Quality of 
Life (QoL) (O‘Brien, 2001) and the stress induced by interaction with health professionals 
(Noyes et al., 1999).  
Hatzmann et al. (2009) explored the influence of demographic and disease-related factors on 
parental Health-Related QoL (HRQoL) and found that poor parental HRQoL is explained 
best by low emotional support, high care dependency, few days on holiday, and being 
chronically ill as a parent. 
Muscular Dystrophy (MD) 
MD refers to a group of neuromuscular disorders affecting the muscles or the nerves 
controlling the muscles. These disorders are generally progressive in nature and often 
terminal. The body‘s muscles become progressively weaker, leading to physical disability 
and often respiratory failure. However, medical advances have resulted in prolonged life 
expectancy for these individuals (Annane et al., 2007). Moreover, services are now 
promoting care in the home (Boström et al., 2006). This has consequently resulted in many 
parents becoming full-time, primary caregivers for a long period of time. 
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Caring for a child with MD 
Many studies focus on the QoL, emotional well-being and social functioning of the children 
with MD and although carers are recruited, the research focuses primarily on the patient 
perspective (e.g. Grootenhuis et al., 2007; Kohler et al., 2005). Other researchers have 
focussed on service provision and service quality for patients and their carers, particularly at 
the end-stages of the illness, with little focus on the carers‘ distress over the trajectory of the 
illness journey (Parker, Maddocks, & Stern, 1999; Dawson & Kirstjanson, 2003). A large 
number of studies involving carers of people with MD have used participant samples that 
include other illnesses requiring long-term care and data for MD cannot be extracted (e.g. 
Brehaut et al., 2009; Dewey & Crawford, 2007). 
In one of the original studies looking at caregiver distress specifically in MD, Buchanan et al. 
(1979) using open-ended interviews found that 76% of families expressed psychological 
distress as a main concern, which in turn led to difficulties in the overall management of the 
child‘s illness. They also identified the need for parents to adapt constantly to their child‘s 
increasing disability, which led the family to perceive restrictions to their freedom and social 
activities. However, the prevailing stressor was the anticipation of the future and that of 
death. 
Parker, Maddocks, & Stern (1999) looked into the role of palliative care in MD by 
interviewing carers and found that there is a communication issue between parents and their 
ill child, since parents felt uncomfortable to discuss end-of-life issues with their child. Firth et 
al. (1983) suggest parents feel ill-equipped to have this conversation and worry about the 
negative impact that ‗knowing‘ might have on their child. Lubowe (1989) suggests that 
family psychotherapy may help promote communication between family members and 
relieve emotional stress, caused by the loss of the ‗perfect‘ child and the process of life-time 
mourning. 
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Polakoff et al. (1998) reviewed the literature on psychosocial factors impacting the lives of 
boys with Duchenne Muscular Dystrophy (DMD) and their families. In line with Lubowe 
(1989), they report that ―...grief has no immediate closure, as exists with a death‖ (p.121) 
since during the course of the illness caregivers may experience numerous emotional traumas 
relating to the illness progression and consequent adjustments that the family is forced to 
make to its lifestyle. This may result in unresolved grief that lingers for years and 
continuously consumes coping resources from the caregivers, leaving them exposed to 
interpersonal and intrapersonal difficulties. 
Polakoff et al. (1998) also identified the following predictors of psychological distress in 
carers: the child‘s severity in loss of functioning – rather than illness severity as rated by 
physicians (Canning et al., 1996); lower family income and patient gender (female; Kazak, 
1987), and mental health difficulties experienced in the family prior to the child‘s illness 
(Kazak, 1989). 
Morrow (2004) also reviewed the literature on DMD and familial distress, basing it on the 
paradigm that the family is the patient. She found that the feelings and thoughts of families 
thirty years ago still seem to reflect those of families now. Perhaps this is because, although 
medical advances allow for better illness management, society‘s expectations of care have 
also increased and thus maintain feelings of anxiety and frustration in carers. The emerging 
themes included guilt towards unaffected siblings, a sense of overprotection, denying the 
child‘s sexuality, developing and adapting coping mechanisms, and the impact on familial 
relationships with mothers carrying most of the burden of care. Importantly, families seem to 
perceive that the psychological stress outweighs the daily physical stresses they experience. 
Miller (1990), and Street and Soldan (1998) argue that distress is not necessarily an ongoing 
difficulty in carers of children with MD. Instead, they propose that distress arises at times of 
crises which closely correspond to the illness progression stages. Miller (1990) explains that 
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distress is the emotional reaction to a deterioration or change. Denial, shock, grief, anger, 
guilt is felt and is worked through until a phase of acceptance is reached which is maintained 
until the next change. 
Street and Soldan (1998) argue that the way an illness progresses will define the psychosocial 
demands placed upon the individual and the family. They present Rolland‘s (1987) 
conceptualisation of the five elements across a range of chronic-illness trajectories which 
group similar psychosocial demands (Table 1). 
Table 1. Rolland‘s (1987) conceptualisation of the nature of psychosocial demands present at 
various stages of a range of chronic illnesses. 
Stage Description Summary 
Onset 
Development of illness and 
symptoms can be sudden or 
gradual. 
Acute versus Gradual 
Course 
Illness and its symptoms may be 
constant, progressive, relapsing 
(stable or progressive), or in 
episodes of varying intensity. 
Constant/Progressive/Relapsing/Episodic 
Outcome 
Effect on life span lies on a 
continuum from very little to 
dramatic (either gradual or 
sudden). 
Prognosis/Morbidity 
Incapacitation 
Nature and degree of physical, 
cognitive, and emotional 
problems can vary. 
Impact (and its severity) on physique, 
cognition, mental health 
Uncertainty 
Characteristic that overlays all 
previous attributes. Knowledge 
about the nature of onset and 
rate of changes define the degree 
of predictability. 
Predictability, e.g. phases, staged 
 
In line with this, parents of chronically-ill children identify that their psychosocial needs 
change over time and corresponding support is needed on the basis of the illness progression 
(McGarth, 2004).  
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Aims of Review 
So far the evidence suggests that parental or carer distress can negatively impact not only the 
context in which a chronically-ill child is cared for (i.e. through familial relationships), but 
also the quality of care they receive and consequently their health and adjustment (Friedman 
et al., 2004). This review therefore aims to address the following questions: 
 How does caring for a child with MD impact on carers‘ psychological well-being, and 
how do they define the distress they experience?  
 In which areas of life is distress felt by carers of children with MD? 
 What are the main factors linked to psychological distress in carers of children with MD? 
 What are the implications for carers, patients, and services, of psychological distress in 
carers of children with MD? 
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Method 
Selection of studies for inclusion 
The following electronic databases were searched in December 2009 and updated in June 
2010, to identify relevant papers for inclusion in the review: PsycINFO, PsychArticles, 
Embase, Medline, Scopus, CINAHL, and Web of Knowledge (all 1980 - 2010). 
Search terms included ‗carers‘, ‗muscular dystrophy‘, and ‗psychological distress‘. These 
were all expanded and the resulting search-term strategies used in PsycINFO (as an example) 
can be seen in Appendices D, E, and F respectively. 
The resulting titles were reviewed and relevant ones were selected. An overview of the 
abstracts further narrowed down the relevant papers, which were then accessed in full for 
reading and assessment against the inclusion/exclusion criteria. The final selected papers 
were then evaluated thoroughly. Reference lists from these papers were hand-searched by the 
author to identify further relevant papers and minimise publication bias (Khan et al., 2001). 
Search selection criteria and paper retrieval 
The search strategy produced 1473 papers, 105 of which were selected through the abstracts. 
Duplicate papers (i.e. papers found in more than one database) were removed (N=27) and a 
further selection of 26 were removed according to the inclusion and exclusion criteria 
outlined in Tables 2 and 3. 
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Table 2. Inclusion criteria and their justification. 
 Criterion Justification 
1 Subjects diagnosed with any type of 
neuromuscular disorder
4
 as defined by 
the World Health Organisation 
Neuromuscular disorders are all rare and thus 
populations and studies are limited – 
specifying a disorder would yield a very 
small number of papers 
2 Study only involves primary carers who 
cohabit with the subject(s) 
Psychological distress will then refer to the 
emotional strains of full-time, 24-hour care. 
A wider range of care-profile would limit 
reliability and validity with which to draw 
conclusions. 
3 Study involves carer self-reports of 
psychological distress using qualitative 
and/or quantitative data 
[NB. Psychological distress includes 
mood difficulties, anxiety/stress, and any 
negative emotional impact as defined by 
the carer] 
Psychological distress is defined as what is 
felt/experienced by the carer. 
Criterion also widens the data availability in 
the literature by including quantitative and 
qualitative data. 
4 Studies published between 1980-2010 Medical advances constantly change the 
management and prognosis of neuromuscular 
disorders – going too far back in time may 
not be representative of present carer distress 
5 Study is on levels 1-4 of Khan et al.‘s 
(2001) study design hierarchy 
Involves primary data that can be extracted 
and evaluated 
6 Studies available in English language Resources are not available for translation 
 
                                                          
4
 Neuromuscular disorders include: Becker muscular dystrophy, Bethlem myopathy, Central 
core disease, Charcot-Marie-Tooth disease (CMT), Congenital muscular dystrophy (CMD), 
Congenital myasthenic syndromes, Congenital myotonic dystrophy, Duchenne muscular 
dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral muscular dystrophy 
(FSH), Fibre-type disproportion, Fibrodysplasia ossificans progressiva (FOP), Inclusion body 
myositis (IBM), Juvenile dermatomyositis, Limb girdle muscular dystrophies, Manifesting 
carriers of Duchenne muscular dystrophy, McArdle's disease,  Merosin-deficient congenital 
muscular dystrophy: MDC1A, Metabolic disorders, Minicore (multicore) myopathy, 
Mitochondrial myopathies, Myasthenia gravis, Myopathy, Myotonias, Myotonic dystrophy, 
Myotubular (centronuclear) myopathy, Nemaline myopathy, Oculopharyngeal muscular 
dystrophy (OPMD), Periodic paralyses, Polymyositis, dermatomyositis and sarcoid 
myopathy, Rigid spine syndrome, Sarcoglycanopathies: LGMD2C, LGMD2D, LGMD2E and 
LGMD2F, Spinal muscular atrophy (SMA), Ullrich congenital muscular dystrophy. 
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Table 3. Exclusion criteria and their justification. 
 Criterion Justification 
1 Data in study involves a mixed sample of 
patients with illnesses other than 
neuromuscular disorders 
[NB. This does not exclude mixed sample 
studies – only mixed data] 
Caring for chronically ill individuals may 
have commonalities with caring for 
neuromuscular patients, however 
differences may also exist – therefore 
specific data of carers for people with 
neuromuscular disorders must be 
extractable 
2 Study compares carer distress in 
neuromuscular disorders field with 
conditions not involving muscle disease 
Excluded only if study does not allow for 
data extraction of each group, i.e. data on 
neuromuscular disorder carers only 
Table 4 outlines Khan et al.‘s suggested study design hierarchy in decreasing levels of 
effectiveness. It was decided to include studies falling into the first four levels. Each study 
design is reported in the synthesis table.  
Table 4. Study design hierarchy. 
Level Description 
1 Experimental studies (e.g. RCT with concealed allocation) 
2 Quasi-experimental studies (e.g. experimental study without randomisation) 
3 Controlled observational studies 
3a Cohort studies 
3b Case control studies 
4 Observational studies without control groups 
5 Expert opinion based on pathophysiology, bench research or consensus 
 
Both quantitative and qualitative studies were included due to the limited research in the area. 
The remaining 52 papers were obtained and studied and 39 of these were excluded on the 
basis of the criteria, while the remaining 13 papers were reviewed. Six papers were selected 
via a hand-search of the reference lists of the 52 papers. Figure 1 illustrates the selection 
process.  
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Figure 1. A flowchart of the paper selection process. 
Data extraction 
A standardized data extraction sheet was piloted with a number of papers, adapted, and used 
throughout the selection process to ensure unbiased information was drawn from each study 
(Appendix G). 
Data synthesis 
A descriptive (non-quantitative) approach was taken in synthesising the data since both 
quantitative and qualitative studies were included and the resulting data were too diverse for 
statistical meta-analysis. 
 
 
Grand total number of papers 
reviewed (N=19) 
Excluded on basis of 
inclusion/exclusion 
criteria (N=39) 
Included on basis of 
inclusion/exclusion criteria 
(N=13) 
Selected from reference lists 
and included (N=6) 
Duplicate papers 
removed 
(N=27) 
Embase 
(N=74) 
Selected 
N=19 
Medline  
(N=71) 
Selected 
N=14 
PsychInfo 
(N=23) 
Selected 
N=11 
Web of 
Knowledge 
(N=111) 
Selected 
N=13 
CINAHL 
(N=762) 
Selected 
N=9 
PsychArti
cles 
(N=72) 
Selected 
N=2 
Scopus  
(N= 360) 
Selected 
N=36 
Total number of papers 
selected through 
abstracts (N=105) 
Papers removed 
according to 
inclusion/exclusion 
criteria (N=26) 
Total number of papers 
read (N=52) 
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Quality assessment 
Quality assessment of the included studies was challenging given the variation in study 
designs and the scarcity of studies looking at psychological distress in carers of people with 
MD specifically. There were no randomised controlled trials; in fact many studies did not 
include matched controls, as most were exploratory in nature perhaps reflecting the limited 
exploration of this field, despite the fact that studies spanned three decades. 
Subsequently, two quality control tools were adapted and used; one for assessing quality of 
qualitative studies and one for quantitative studies. The National Institute of Health and 
Clinical Excellence (NICE) published guidelines on checklists used to review clinical 
evidence. An adapted version of the NICE Guidelines (2009) checklist for assessing 
qualitative research was used, fitting with the aims of this review (Appendix H). The 
checklist comprised of several areas for reviewing quality, each of which was assigned either 
a score of 2 (if the criterion was fully satisfied), 1 (if it was partially satisfied), or 0 (if it was 
not satisfied). The maximum score obtainable was 28.  
Similarly, an adapted version of the Downs and Black (1998) checklist for quantitative 
studies was also used (Appendix I). Although this checklist was compiled for use with 
intervention studies, many of the areas for quality review applied well to observational 
studies. A total of 11 items were excluded from the checklist. The maximum score obtainable 
was therefore 16. 
Each study was given a quality score based on the checklist used, which was reported in the 
synthesis table. Appendix J outlines the quality scoring assigned to each study. Five papers 
were randomly selected and assessed on quality using the checklists by an independent 
reviewer. Inter-rater reliability was assessed and Cohen‘s Kappa was found to be .64, which 
is considered ‗substantial agreement‘ by Landis and Koch (1977).  
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Results 
Summary of studies 
Table 5 shows a summary of the main characteristics of the studies included in the review 
and is accompanied by a key to abbreviations used. Study reference numbers have been 
allocated to assist the presentation and discussion of the results. 
Seven of the 19 studies were qualitative and twelve were quantitative. Two studies involved a 
comparison with a non-MD group. Three studies involved a mixed sample where MD data 
was extractable. Twelve studies used a DMD population to investigate their research 
questions, one study used Spinal Muscular Atrophy, and the remaining six used a range of 
neuromuscular disorders. Five out of twelve quantitative studies did not use a matched 
control group. 
21 
 
Table 5. Main characteristics of the studies included in the review (N=19). 
Study 
ID 
refere
nce 
Reference & 
Country 
Study design 
(1-4) & 
Quality score 
(QN/QL) 
N & Patient 
sample 
characteristics 
(diagnoses, 
ages) 
Carer 
characteristic
s (N, NRPP, 
ages, RTP) 
Outcome measures & 
Analyses 
Main Findings 
Main Findings in 
relation to 
psychological 
distress in carers 
1 Webb (2005) 
 
 
USA 
Observational 
– without 
control 
 
QL = 21 
 
N=13 (15 
families) 
 
Diagnosis – 
DMD 
 
Age range = 5-
23 
N=23 
 
NRPP – 1 for 
N=7 and 2 for 
N=8 
 
Age range = 
N/A 
 
RTP = Parents 
(mothers N=7, 
fathers N=1, 
couples N=7) 
Semi-structured 
interviews – lasting 1-
2 hours 
 
Grounded theory 
analysis of interview 
data (used coding 
organised in loose-leaf 
Concept Notebook, 
then used cut-up-and-
put-in-folders method) 
 
Coping themes 
emerged: Genetics, 
Diagnosis, Reactions to 
the Diagnosis, 
Treatment, Equipment, 
and School Issues. 
 
Most parents coped 
realistically and 
positively. They want to 
be valued as experts in 
DMD by professionals 
and share information 
with other parents to 
feel empowered. 
 
Parents face much 
distress and 
emotional tension at 
various stages of 
illness – yet seem to 
hold a realistic and 
positive attitude so 
although distressed 
can manage well and 
keep going. 
2 Chen et al. 
(2002) 
 
 
China 
Observational 
- Case-control 
 
QN = 15 
MD – N=22 
Control – N=30 
 
Diagnoses – 
DMD; children 
with fever 
 
Ages: MD 
µ=10.9(3.9), 
Control 
µ=3.6(2.5) 
MD-N=31 (22 
families) 
Control-N=30 
 
NRPP= 1-2 
 
Ages: MD 
µ=37.9(7.5), 
Control 
µ=32(3.6) 
 
RTP=Parents 
CICI (Foxall & 
Watson, 1988; 
Hymovich, 1983), 
Coping Scale (Felton, 
Revenson, & 
Hinrichsen, 1984) 
 
Multivariate analyses 
using stepwise 
logistical regression 
Control group – higher 
―stress,‖ ―conflict,‖ and 
―help needs.‖  
DMD group – 
significantly less likely 
to use emotional 
expression. Parents' 
gender was non-
significant in 
influencing variables. 
―Impact‖ was influenced 
by income and religion; 
DMD parents 
indicated 4 times 
lower stress than 
controls. DMD 
parents were less 
likely to use 
emotional expression 
and self-blame for 
coping, but used 
wish-fulfilling 
fantasy more. 
Mothers of DMD 
22 
 
Study 
ID 
refere
nce 
Reference & 
Country 
Study design 
(1-4) & 
Quality score 
(QN/QL) 
N & Patient 
sample 
characteristics 
(diagnoses, 
ages) 
Carer 
characteristic
s (N, NRPP, 
ages, RTP) 
Outcome measures & 
Analyses 
Main Findings 
Main Findings in 
relation to 
psychological 
distress in carers 
(fathers N=14, 
mothers N=17) 
and income and 
mother‘s age influenced 
coping strategies (higher 
income & younger 
mothers more likely to 
use them). 
showed higher 
conflict and help 
needs than the 
fathers, while fathers 
needed more 
information and 
needed to receive 
more help from 
resources. Higher 
income and no 
religion showed 
greater risk for illness 
impacting on parent. 
 
3 Gravelle (1997) 
 
 
Canada 
Observational 
– without 
control 
 
QL = 22 
N=8 
 
Diagnoses - 
DMD, SMA, 
ML, Retts 
syndrome, and 
CP 
 
Age range=2-16 
N=11 
 
NRPP= 1-2 
 
Age range = 
N/A 
 
RTP=mothers 
(N=5), 
parental 
couple (N=6) 
Initial unstructured, in-
depth interviews 
lasting 35 minutes - 2 
hours, using trigger 
questions for focus. 
Second interviews 
were semi-structured 
(based on 1
st
 
interviews), clarifying 
information, and 
validating findings. 
 
Used Giorgi's data 
analysis & 
phenomenological 
analysis. Verified 
Main theme of ‗facing 
adversity‘ through 
offering care emerged. 
Parents had to 
continuously redefine 
and manage changes 
(increase in burden of 
care) resulting from the 
progressive nature of 
illness. Normalisation 
and ‗chronic sorrow‘ are 
part of theme, as are the 
challenges of care-
giving (particularly of 
mothers). 
Parental distress was 
reported as highest at 
times of illness 
progression 
(adversity) and 
through each new 
stage (as 
normalisation 
becomes harder to 
achieve). Losses (of 
child's abilities and of 
caregiver freedom) 
lead to recurrent 
grief. Mothers willing 
and able to share their 
care-giving role 
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emerging themes with 
3 carers. 
reported less stress 
than those who 
weren't (i.e. if 
accepted role due to 
no other choice then 
became resentful and 
frustrated). 
 
4 Abi Daoud et al. 
(2004) 
 
 
Canada 
Observational 
- Case-control 
 
QN = 13 
MD – N=27 (26 
families) 
Control – 
N=132 
 
Diagnoses – 
DMD; general 
population 
 
Age 
median=13.5 
(11-19) 
N=42  
 
NRPP= 1-2 
 
Age range=25-
54 
 
RTP= mothers 
(N=25), 
fathers 
(N=14), 
stepfathers 
(N=2), foster 
mother (N=1) 
Questionnaire based 
on (or (for controls) 
information from) the 
National Population 
Health Survey from 
Statistics Canada 
(Scales measured: 
depression, self-
esteem, mastery, 
distress) 
 
Chi-squared analysis 
and Fisher‘s exact test, 
t-tests and 
nonparametric tests for 
comparisons between 
groups 
 
 
DMD parents showed 
higher probability of a 
major depressive 
episode and 
significantly lower self-
esteem and mastery 
scores than controls. No 
variables (age, IQ, and 
ambulatory status of 
child, or sex, age, and 
marital status of parent) 
predicted any of the 
scales, with 2 
exceptions: single 
parents had lower scores 
on the mastery scale; 
and parents of either 
males, or older than 13 
years were more likely 
to experience distress. 
 
 
Psychological 
distress in DMD 
parents was more 
likely than in controls 
in terms of low 
mood, poor self-
esteem, and low 
sense of mastery. 
Single parents were 
most at risk of low 
mastery, while 
parents of males or 
older than 13yrs were 
at risk for more 
distress. 
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5 Boyer et al. 
(2006) 
 
 
France 
Observational 
– without 
control 
 
QN = 12 
N=56 
 
Diagnoses - 
DMD (N=11), 
BMD (N=14), 
SM (N=10), 
FSHM (N=5), 
C-MD (N=3), 
LG-MD (N=4), 
SMA (N=5), U-
MD (N=4) 
 
Age µ=32.7 
(range=15-65) 
N=56 
 
NRPP=1 
 
Age µ=48 
(range=30-80) 
 
RTP=mothers 
(N=29), 
fathers (N=5), 
spouses 
(N=17), 
friends (N=3), 
half-sister 
(N=1), 
grandmother 
(N=1) 
Patients: WIS (Walton 
et al., 1994), Modified 
Barthel Index (Collin 
et al., 1988), Katz 
scale (Katz et al, 
1970), socio-
demographic data , 
SF-36. 
Carers: ZBI (Bocquet 
et al., 1996), SF-36 
(McHorney et al., 
1994), GHQ-12 
(Goldberg, 1979), 
HADS (Snaith, 2003), 
socio-demographic 
data, no. of care hours 
provided, no. of 
external-care hours per 
week. 
 
Bivariate analyses to 
determine explicative 
factors of perceived 
degree of burden. 
Multivariate analysis 
using logistic 
regression model to 
find variables 
explaining care burden 
and perceived HRQoL. 
High burden of care 
reported (on ZBI). 
Carer characteristics 
related to high risk of 
perceived burden are: 
self-report of poor social 
functioning on the SF-
36; self report of anxiety 
on the HADS; and being 
a carer under 48 years 
old. 
Physical dependency, 
patient characteristics, 
and level of formal 
assistance provided 
were not associated with 
perceived burden of 
care. 
Carers of people with 
MD can be at risk of 
high burden of care 
(physical and 
emotional) as defined 
by the ZBI and of 
perceived poor 
HRQoL as measured 
by the SF-36. (Study 
also attempted to 
identify explicative 
factors of poor 
HRQoL - namely 
social functioning, 
anxiety on HADS, 
and <48 yrs old; 
however admit this 
list is not exhaustive). 
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6 Bach et al. 
(2003) 
 
 
USA 
Observational 
- Case-control 
 
QN = 12 
MD-N=47 
Control-N=30 
 
Diagnoses – 
SMA; healthy 
children 
 
Ages=N/A 
MD-N=104 
Control-N=30 
 
NRPP=varied-
unspecified 
 
Ages=N/A 
 
RTP=mothers 
(N=44), 
fathers 
(N=30), 
grandparents 
(N=8), nurses 
(N=20) 
Likert-scales on 6 QoL 
issues (1. Child‘s 
QoL? 2. Your QoL? 3. 
Effort to care for 
child? 4. Burden of 
caring for child? 5. 
How happy is the 
child? 6. Child‘s life 
worth living?) & 
choosing 10 polar-
adjectives (e.g. 
hard/easy, 
miserable/enjoyable) 
 
One-way ANOVA and 
Mann-Whitney U test 
used. 
Carers indicated high 
QoL for both children 
and themselves. Despite 
higher effort (‗harder 
life‘) rated by these 
carers when compared 
to parents of unaffected 
children, burden was not 
rated as higher. 
However: fathers report 
less burden of care than 
mothers; nurses report 
better personal QoL 
than both parents; 
nurses report more 
effort in caring for child 
than parents; nurses 
report more burden of 
caring for child than 
parents; grandparents 
report less burden of 
caring for child than 
parents; severity of 
illness did not play 
significant role in carer 
ratings of QoL. 
 
 
 
 
Carers experience 
good perceived QoL 
while at the same 
time recognising that 
their life is harder 
than that of a parent 
of a healthy child. 
Parental gender (and 
possibly their 
responsibilities) may 
influence perception 
of burden. Parental 
relationship may have 
a positive impact on 
perception of QoL, 
burden, and effort. 
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7 Dawson & 
Kristjanson 
(2003) 
 
 
Australia 
Observational 
– without 
control 
 
QL = 26 
N=16 
 
Diagnoses-
MD(N=11), 
MND(N=5) 
 
Ages=N/A 
N=16(MD-
N=11) 
 
NRPP=1 
 
Ages=N/A 
 
RTP=Familial 
Semi-structured 
interview (1-2 hours) 
based on literature and 
clinical experience.  
 
Content analysis and 
constant comparison 
techniques used to 
code interviews and 
yield the three key 
themes (and 
subthemes). 
Themes: reactions and 
responses (grieving 
every day, fearing each 
crisis may mean the end, 
watching life in 
reverse), health system 
crossing points (getting 
lost in the system, living 
with limits, I want to 
know who do I ask?), 
reaching forward 
(holding on to the big 
picture, learning from 
other carers, needing 
help to plan the future, 
just getting on with it, 
don't forget the children) 
 
Many areas of stress 
for parents revealed - 
not only related to 
managing child's 
illness (constant 
progressive changes), 
but also to services 
available and to 
adjustment to new 
life. Complex 
emotional processes 
(e.g. grief) noted 
relating to different 
areas of impact in 
parent's life (family, 
marital, social, 
leisure/personal). 
8 Reid & Renwick 
(2001) 
 
 
Canada 
Observational 
– without 
control 
 
QN = 15 
N=32 (36 
families) 
 
Diagnoses-
DMD 
 
Age µ=14.9 
(1.92) 
N=36 
 
NRPP=1 
 
Age µ=43.05 
(5.52) 
 
RTP=parents 
(N=35), 
grandmother 
(N=1) 
QRS ( Holroyd, 1987), 
OSIQ (Offer et al., 
1989), 
Sociodemographic, 
disorder-related and 
other measures via 2 
author-developed 
questionnaires, PPVT-
R (Dunn&Dunn, 1981) 
 
Means (SD) calculated 
for each measure and 
Satisfaction with how 
diagnosis was delivered 
was almost equally split 
(47% dissatisfied Vs 
44% satisfied). 
Perception of who found 
it hardest to cope 
revealed highest % was 
fathers (28%), followed 
by mothers (16%), and 
both equally affected 
(16%). QRS showed 
Familial/caregiver 
stress reported is high 
although not above 
measure's threshold - 
however study found 
that carer stress was 
high enough to 
impact negatively on 
(and predict) child 
adjustment in the 
areas of impulse 
control 
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comparison of scores 
made to measures' 
norms using t-tests. 
Pearson correlations 
used to examine r/s 
between familial stress 
and psychosocial 
adjustment and 
function. Stepwise 
regression analysis 
conducted to 
determine variables 
best predicting level of 
psychosocial 
adjustment. 
 
high familial stress (just 
under clinical cut-off). 
Familial stress was 
significantly correlated 
with adolescent 
adjustment (OSIQ). 
Adolescents‘ scores on 
OSIQ were significantly 
predicted by caregivers‘ 
scores on QRS alone. 
 
(psychological self), 
morals (social self), 
and family 
relationships (familial 
self). 
 
9 Mah et al. 
(2008a) 
 
 
Canada 
Observational 
– without 
control 
 
QL = 24 
N=15 
 
Diagnoses-
DMD (N=3), 
SMA (N=5), 
other MD (N=7) 
 
Age range=2-7 
N=19 
 
NRPP=1-2 
 
Age range=24-
47 
 
RTP=mothers 
(N=14), 
fathers (N=5) 
Semi-structured 
interviews (60-90 
minutes) based on 
previous study but 
adapted to focus on 
research question.  
Computer software 
used to facilitate 
interpretation within a 
phenomenological 
framework. 
Main themes: context of 
mechanical ventilation; 
caregiving; child's life 
and QoL; isolation; 
stress; support, 
uncertainty; living with 
loss; expert; changed 
perspective. Central 
theme of parents‘ 
experience was being 
the ‗‗lifeline‖ for their 
child‘s life and QoL. 
Experience of recurrent 
sense of loss and 
Distress expressed by 
parents particularly in 
view of insufficient 
support (health-care 
services) or isolation 
(social). However, 
driving force to 
continue giving care 
was the overarching 
experience of being a 
―lifeline‖ for child 
and their child‘s QoL. 
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uncertainty, despite 
expertise in care-giving. 
Those who perceived 
insufficient support felt 
weight of responsibility 
as sole carers. 
 
10 Mah et al. 
(2008b) 
 
 
Canada 
Observational 
- Case-control 
 
QN = 16 
N=109 
(ventilated 
N=19, non-vent. 
N=90) 
 
Diagnoses-
DMD/BMD 
(N=24), C-MD 
(N=6), 
Myotonic 
dystrophy 
(N=3), FSHM 
(N=2), U-MD 
(N=2), 
Myopathies 
(N=19), SMA 
(N=17), 
Neuropathies 
(N=33), O-
NMD (N=3) 
 
Age µ=10.5 
(5.2) 
N=109 
 
NRPP=1 
 
Age µ=41 (8) 
 
RTP=mothers 
(N=87), 
fathers 
(N=17), legal 
guardian 
(N=5) 
PSI (Abidin, 1995) or 
SIPA (Sheras et al., 
1998), PQoLI (Varni 
et al., 2001), a general 
survey of child‘s 
neuromuscular disease 
and family‘s socio-
demographic 
characteristics 
 
Bivariate comparisons 
using Pearson‘s chi-
square or Fisher‘s 
exact test on 
categorical variables. 
Continuous variables 
reported as means 
(SD) or medians 
(interquartile range) 
and comparisons using 
unpaired Student t-
tests or one-way 
ANOVA. 
Children on ventilation 
had significantly lower 
mean total PQoLI scores 
than non-ventilated 
children.  
No significant 
difference in parental 
stress between 
ventilated and non-
ventilated children.  
No significant 
difference in mean total 
stress scores found 
between parents (with or 
without ventilation) than 
normative sample.  
 
Distress expressed in 
both groups of MD 
parents but no 
difference in stress 
levels between 
parents of ventilated 
and non-ventilated 
children; nor was 
distress above clinical 
threshold. Added 
caretaking demands 
of parents of 
ventilated children 
seem to be adjusted 
to and not identified 
as creating additional 
stress. 
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11 Nereo et al. 
(2003) 
 
 
USA 
Observational 
- Case-control 
 
QN = 14 
MD-N=112 
Control 1-N=28 
Control 2-N=46 
Control 3=scale 
norms 
 
Diagnoses-
DMD, CP 
(N=28), siblings 
(N=46) 
 
Ages: DMD 
µ=9.43 (2.81), 
CP µ=6.43 
(0.63), siblings 
µ=10.07 (3.2) 
MD-N=112 
CP-N=28 
Siblings-N=46 
 
NRPP=1 
 
Ages: DMD 
µ=37.75 
(5.43), CP 
µ=36.75 
(5.61), siblings 
µ=37.90 (5.30) 
 
 
RTP=mothers 
Mothers: PSI-SF 
(Abidin, 1995), CBCL 
(Achenbach, 1991). 
Longitudinal testing of 
maternal PSI-SF in 
DMD (3 time-points). 
DMD and siblings: 
PPVT-R; Dunn & 
Dunn, 1981). 
 CP: PPVT-Third 
Edition (Dunn & 
Dunn, 1997). 
 
One-sample t-tests to 
compare DMD PSI-SF 
to norms. Linear 
regression analyses to 
determine contribution 
of variables to stress. 
MANOVA to compare 
CBCL results between 
‗stressed‘ and ‗non-
stressed‘ mothers. 
ANCOVA (CP) or 
paired t-tests (siblings) 
used to compare DMD 
PSI-SF scores. General 
linear model to 
compare PSI-SF 
longitudinally. 
Presence of problem 
child behaviours 
predicted maternal 
distress, parent-child 
interaction problems, 
and child being 
perceived as difficult. 
Stress related to child 
behaviour was higher in 
DMD versus normative 
group. No differences in 
stress were found 
between DMD versus 
CP or versus siblings. 
Longitudinally, DMD 
maternal stress reduced 
with disease 
progression. 
 
Distress was not 
higher in DMD 
mothers than in 
normative sample. 
But stress was higher 
relating to child‘s 
problem behaviours, 
and to social 
interactions with 
child. Thus higher 
stress seems to be 
related to those 
factors rather than 
due to the physical 
demands of the 
illness alone (since 
symptom progression 
alone could not 
account for stress 
levels, suggesting 
mothers learn to cope 
with increasing 
burdens and child 
social interactions). 
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12 Samson et al. 
(2009) 
 
 
Canada 
Observational 
– without 
control 
 
QL = 26 
N=11 (9 
families) 
 
Diagnoses-
DMD 
 
Age median=15 
(range 7.5-17) 
N=12 
 
NRPP=1-2 
 
Age 
median=48 
(range 41-60) 
 
RTP=mothers 
(N=7), fathers 
(N=5) 
Semi-structured 
interviews – duration 
µ= 90 min. Three 
types of interjections 
used by interviewers. 
 
Empirical 
Phenomenological 
Psychological data 
analysis method used. 
Three major themes 
indicated ways of 
perceiving child‘s 
illness: (1) a severe loss 
to face, (2) a call to 
adapt, and (3) seeing 
beyond the loss to 
rediscover child.  
Each of the 3 cognitive 
appraisals leads to 
different ways of 
hoping. Parents can 
hope for (1) a cure, (2) 
the child‘s well-being, 
or (3) to see their child 
becoming a whole 
person. Hope can help 
parents absorb the initial 
crisis, sustain their 
adaptation, or prepare 
for the fatal outcome. 
 
 
 
 
 
 
 
 
 
Parents seem to move 
through the 3 
cognitive appraisals 
from diagnosis to the 
terminal stages, as 
child grows older. A 
very positive view of 
care-giving and 
working through the 
distress, so life is 
enjoyed within the 
context of evolving 
(from wishful 
thinking to more 
reality-based) hope 
(an inner supporting 
resource). 
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13 Bothwell et al. 
(2002) 
 
 
Canada 
Observational 
– without 
control 
 
QN = 12 
N=31 families 
 
Diagnoses-
DMD 
 
Age µ=11.4 
(4.7) 
N=31 
 
NRPP=1 
 
Age 
range=N/A 
 
RTP=parents 
Postal questionnaire 
developed on basis of 
DMD literature and 
clinical practice, rating 
importance of: 
services, health issues, 
& QoL issues, both 
‗now‘ and ‗in the 
future‘. 
 
Calculated proportion 
of patients answering 
‗very important‘ on 
each item. Compared 
responses to questions 
‗now‘ versus in 
‗future‘ using 
Wilcoxon signed-rank 
test. Compared 
responses between 
parents whose boys 
were within 6yrs of 
diagnosis 
to those beyond 6yrs 
using ANOVA to 
identify changes in 
importance as disease 
progressed. 
 
 
Overall, 
Psychology/Psychiatry 
seldom considered 
important service (now 
or in future) but parents 
of older children 
(diagnosis >6yrs) saw 
psychiatry as likely to 
be important in the 
future. QoL and 
educational issues were 
important (now and in 
the future). Financial 
concerns, anger, and 
social isolation for both 
parent and child were 
important now and were 
predicted to increase in 
future.  
 
Mental health and 
QoL are important to 
families. Parents 
concerned about 
anger, finance, and 
social isolation for 
child and themselves. 
Felt that depression 
and anger in their son 
and family would 
become more 
important in future. 
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14 Thompson et al. 
(1992) 
 
 
USA 
Observational 
– without 
control 
 
QN = 14 
N=35 
 
Diagnoses-
DMD 
 
Age range=4-14 
N=35 
 
NRPP=1 
 
Age 
range=N/A 
 
RTP=mothers 
(N=32), 
fathers (N=3) 
Stress and efficacy 
ratings (0-100) given 
on 4 illness-related 
tasks: Dealing with 
child‘s medical prbs, 
Maintaining child‘s 
emotional well-being, 
Maintaining own 
emotional well-being, 
Preparing for an 
uncertain future. WCQ 
(Vitaliano et al., 
1985), FES (Moos & 
Moos, 1981), SCL-90-
R (Derogatis, 1977). 
MCBC (Sines et al., 
1969). 
 
MANOVAS/ANOVA
S, Pearson 
correlations, and 
hierarchical multiple 
regression conducted. 
 
57% of parents 
(primarily mothers) 
reported poor 
adjustment, 37% 
showed clinical distress, 
29% depression, and 
20% anxiety. Poorly 
adjusted parents 
reported higher stress in 
maintaining own 
emotional well-being. 
Palliative coping was 
used more than adaptive 
coping. Low levels of 
family support, and high 
levels of family conflict. 
Parental stress, 
depression, and anxiety 
accounted for 58% of 
variance in general 
distress, 50% in 
depressive symptoms, 
and 31% in anxiety 
symptoms. 
89% reported poor child 
adjustment which was 
predicted by parental 
variables. 
 
 
Poor parental and 
child adjustment 
found. High rate of 
child behavioural 
problems may reflect 
parental distress. 
High levels of 
parental-perceived 
stress, palliative 
coping methods 
relative to adaptive 
methods, and high 
levels of family 
conflict were 
associated with 
parental poor 
adjustment. 
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15 Hatzmann et al. 
(2008) 
 
 
Netherlands 
Observational 
– case-control 
 
QN = 14 
MD-N=57 
Control-N=425 
 
Diagnoses-
DMD, healthy 
children 
 
Ages: MD 
range=7.6-15.6, 
Control 
range=1-19 
MD-N=57 
Control-
N=425 
 
NRPP=1 
 
Ages: MD 
range=38.4-
49.6, Control 
range=38.2-
49.2 
 
RTP:MD-
mothers 
(N=42), 
fathers 
(N=15), 
Control-
mothers 
(N=354), 
fathers (N=71) 
TAAQoL (Bruil et al., 
2004) 
 
Univariate ANOVA 
carried out for each 
scale of TAAQoL. 
Effect sizes (d) 
calculated. Used 25th 
percentile ranking of 
healthy population as 
cut-off between 
parents 'at risk' and 
those 'not at risk' for 
impaired HRQoL. 
 
 Four significant areas 
of difference found 
between DMD and 
controls (DMD did 
worse): social 
functioning, vitality, 
positive emotions, and 
depressive emotions. 
DMD parents found to 
be significantly 'at risk' 
for impaired HRQoL 
compared to controls on 
social functioning, 
vitality, and depressive 
emotions.  
 
Parental distress was 
higher in DMD than 
controls with certain 
aspects of life under 
particular stress, i.e. 
social functioning, 
vitality, and mood.  
16 Firth et al. 
(1983) 
 
 
UK 
Observational 
– without 
control 
 
QL = 21 
N=56 (53 
families) 
 
Diagnoses-
DMD 
 
Age range=4-
young adults 
N=53 families 
 
NRPP=1-2 
 
Age 
range=N/A 
 
RTP=parents 
Guided interviews – 
duration= 1-2½ hours. 
Authors designed 
interview schedule 
covering: problems 
experienced by 
parents, diagnosis, 
neonatal screening, 
effects on marital 
15% of reported 
problems were classed 
as ‗emotional‘ (‗service‘ 
- 23%, ‗practical‘ - 
62%). Parental 
emotional difficulties 
reported by 6%. 
Isolation and additional 
problems of mental 
Insufficient or 
inappropriate support 
when needed is 
perceived by parents, 
which adds to their 
emotional stress. 
Communication 
within family around 
illness is a constant 
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relationship, siblings, 
effects of DMD on 
sufferers, and 
information. 
 
Interview coding 
developed by authors, 
as well as verbatim 
transcriptions of 
extracts were used. 
 
handicap reported by 
4%. Mainly mothers 
reported fathers found 
diagnosis harder to 
accept. Neonatal 
screening: majority in 
favour (75%) and 1 of 
reasons was emotional 
advantage of more time 
to adjust. 11 reported 
negative effect on 
marital relationship. 
Siblings: parents felt 
guilty about neglect or 
being inappropriately 
stricter & worried about 
accepting help versus 
being a 'burden'. 
Worried over son‘s 
well-being and 
concerned about what to 
tell sons about illness. 
 
worry. Worry felt 
primarily around time 
of diagnosis, but 
carries on throughout 
caring for child and 
spreads to other 
areas, such as 
siblings. 
17 Gagliardi (1991) 
 
 
USA 
Observational 
– without 
control 
 
QL = 25 
N=3 
 
Diagnoses-
DMD 
 
Age range=7-9 
N=6 
 
NRPP=2 
 
Age range=26-
30 
 
Ethnographic logs and 
memos kept during 
observations. In-depth 
interviews conducted 
twice over 10-week 
observation period, 
and third time 1 year 
6 themes emerged and 
were grouped under 3 
stages of adapting to 
disability: Stage 1-
Recognition: (1) 
Disillusionment, (2) 
Society confirms the 
Parental distress 
evident within family 
life, social 
functioning, 
emotional 
functioning, marital 
relationship, through 
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Main Findings 
Main Findings in 
relation to 
psychological 
distress in carers 
RTP=mothers 
(N=3), fathers 
(N=3) 
later.  
 
Constant comparative 
method used as 
context of analysis. 
Coding used to 
compare across 
families. 
 
impossibility of 
normalcy; Stage 2-
Working out: (3) 
Dynamics of family, (4) 
A smaller world; Stage 
3-Resolution: (5) 
Letting go or hanging 
on, (6) Things must 
change 
the themes identified. 
However, the 
families rise to the 
challenge by the end 
and make the most of 
their lives, giving a 
sense that distress is 
manageable and can 
be overcome. 
 
18 Holroyd & 
Guthrie (1986) 
 
 
USA  
Observational 
– case-control 
 
QN = 12 
MD-N=16 
Control 1-N=16 
Control 2-N=11 
Control 3-N=14 
 
Diagnoses-PMD 
(N=11), SMA 
(N=3), MO 
(N=1), O-MD 
(N=1), CF 
(N=16), RD 
(N=11), healthy 
children (N=14) 
 
Ages: MD 
µ=9.7 (2), CF 
µ=10.9 (2.7), 
RD µ=12.5 (5), 
controls µ=9.9 
(2.9) 
MD-N=16 
CF-N=16 
RD-N=11 
Control-N=14 
 
NRPP:1 
 
Age ranges: 
N/A 
 
RTP: Parents 
QRS (Holroyd, 1974), 
QRS-Short Form 
(Holroyd & Guthrie, 
1986) 
 
MD compared with 
control group, CF, and 
RD groups, on 15 QRS 
scales and 11 'short' 
scales using t-tests for 
unrelated means (26 
tests). 
 
MD parents reported 
more stress than CF and 
RD groups. MD parents 
scored significantly 
higher than controls on 
11 out of 15 QRS scales 
(poor health/mood, 
negative attitude 
towards ill child, 
overprotection/dependen
cy, lack of social 
support, pessimism, 
financial problems, 
physical incapacitation 
of child, lack of 
activities for child, 
occupational limitations 
for child, social 
obtrusiveness, difficult 
personality 
Higher parental stress 
experienced in MD 
group than in healthy 
controls, CF, or RD 
populations. 
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characteristics) & 6 out 
of 11 of the short-form 
(cognitive impairment, 
limits on family 
opportunities, life span 
care, terminal illness 
stress, physical 
limitations, financial 
stress). 
 
19 Im et al. (2010) 
 
 
South Korea 
Observational 
– without 
control 
 
QN = 14 
N=90 
 
Diagnoses-
DMD (N=67), 
BMD (N=3), 
myotonic 
dystrophy 
(N=5), LG-MD 
(N=4), C-MD 
(N=1), U-MD 
(N=10) 
 
Age µ=14.5 
(7.3) 
N=90 
 
NRPP=1 
 
Age µ=42.9 
(8.7) 
 
RTP=mothers 
(N=81), 
fathers (N=4), 
other (N=5) 
K-WHOQOL BREF 
(Min et al., 2002); K-
BDI (Rhee et al, 
1995); K-APGAR 
(Choi et al., 2002); 
emotional status of 
patients measured by 
K-BDI and K-CDI 
(Cho & Lee, 1990) for 
patients under 18 yrs. 
 
Caregivers divided 
into 2 groups on basis 
of DMD, depression, 
carer gender, 
employment status, 
and religious degree. 
Independent t-tests 
compared groups in 
relation with QoL. 
Higher family income, 
high family function and 
education were 
associated with higher 
carer QoL. Depression 
in carers and children 
were associated with a 
lower QoL. Employed 
carers showed 
significantly higher 
QoL. Linear regression 
analyses showed that 
emotional and 
employment status 
accounted for 15.6% of 
QoL. 
 
MD parental QoL 
was linked to their 
own emotional 
distress (28.7% of 
sample had moderate 
to severe depression) 
and their child's 
emotional distress 
(where high 
depression linked to 
low QoL), and their 
employment status 
(employed had higher 
QoL). High income 
and good family 
function were also 
linked to higher QoL. 
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Linear regression with 
stepwise variable 
selection to identify 
factors associated with 
QoL. 
QN = Quantitative checklist used (maximum score of 16), QL = Qualitative checklist used (maximum score of 28); Patient/Carer ages are reported in years using the mean(standard deviation), 
median(interquartile range), or the range, whichever was available; DMD = Duchenne Muscular Dystrophy; MD=Muscular Dystrophy; LM=metachromatic leukodystrophy; BMD=Becker‘s 
Muscular Dystrophy; SM=Steinert's myotonia, FSHM=facio-scapular-humeral myopathy, C-MD=congenital MD, LG-MD=limb girdle MD, SMA=spinal muscular atrophy; U-
MD=undetermined MD; MND=Motor Neurone Disease; O-NMD=Other neuromuscular disorders; CP=cerbral pulsy; PMD=progressive MD; MO=myositis ossificans; CF=cystic fibrosis; 
RD=Renal disease; NRPP = number recruited per participant; RTP= relation to participant; N/A = information not available/reported; CICI=Chronic Impact and Coping Instrument; 
WIS=Walton Impairment Score; SF-36=Short-Form 36 HRQoL; ZBI= Zarit Burden Inventory; GHQ-12=General Health Questionnaire; HADS=Hospital Anxiety and Depression Scale; 
QRS=Questionnaire on Resources & Stress; OSIQ= Offer Self-Image Questionnaire for Adolescents; PPVT-R= Peabody Picture Vocabulary Test-Revised; PSI= Parenting Stress Index; PSI-
SF= Parenting Stress Index-Short Form; SIPA= Stress Index for Parents of Adolescents, PQoLI= Pediatric Quality of Life Inventory; CBCL=Child Behavior Checklist; WCQ=Ways of coping 
questionnaire; FES=Family Environment Scale; SCL-90-R=Symptom Checklist 90-Revised; MCBC=Missouri Children‘s Behaviour Checklist; TAAQoL=TNO-AZL Questionnaire for Adult's 
Health Related Quality of Life; K-WHOQOL BREF=Korean version of World Health Organization Quality of Life Assessment, Life Brief Form, K-BDI=Korean version of Beck Depression 
Inventory; K-APGAR=Korean version of the family APGAR scale; K-CDI=Korean version of the Children‘s Depression Inventory 
Carer distress 
Degree and nature of distress 
Most studies suggested the presence of some form and degree of distress in carers of people 
with MD, although there were a number of studies which indicated that distress in this 
population may not be as debilitating as hypothesised (1, 2, 6, 11, 12, 17). 
Attempts to quantify the level of distress are mostly seen in quantitative studies, where 
several found clinical levels of distress for the measures they used; including measures of 
stress, anxiety, depression, self-esteem, adjustment, coping, and QoL (4, 5, 14, 15, 18, 19).  
Looking at the nature of the distress may be a more meaningful exploration of distress.  A 
major aspect of distress appears to be grief in response to diagnosis and ongoing losses 
occurring as the illness progresses, and the demand for constant adjustment of carer and 
family functioning (1, 3, 7, 9, 12, 14, 16, 17). Throughout the illness trajectory carers are 
repeatedly faced with progressive loss in their child‘s abilities, and subsequently a 
progressive increase in the emotional and practical burden of care.  In fact, Bothwell et al. 
(2002) found that parents of boys with DMD predicted that their anger and social isolation 
would increase in the future and that their sons‘ emotional well-being would deteriorate in the 
future in terms of anger and depression. Gravelle‘s (1997) main emerging theme was that of 
‗facing adversity‘ by redefining and managing the care parents provided through 
normalisation and ‗chronic sorrow‘. Samson et al. (2009) explored the experiences of carers 
for boys with DMD and found that these carers‘ adjustment to the illness and care demands is 
progressive and follows the illness and the child‘s development. 
Distress in varying aspects of life 
Other studies have presented the psychological, social, interpersonal, physical and financial 
(9, 16, 18, 19) aspects of life affected by distress. In particular, the impact on QoL has been 
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investigated with mixed findings. Some studies have found this to be low, or worse in MD 
carers when compared to controls (5, 15, 19), while Bach et al. (2003) found no difference, 
although they used a small and arguably unrepresentative sample of SMA patients.  
Many qualitative studies reveal distress in areas such as social integration resulting in 
loneliness and a sense of isolation (7, 9, 14, 17, 18). Others highlight interpersonal difficulties 
within the family (9, 14), i.e. marital conflict (7, 16, 17), or guilt around neglecting or 
overbearing unaffected siblings (16). Others yet, have found that the carers‘ relationship with 
the affected child is tense (18), assimilating mutual feelings of anger, guilt, and worry; 
particularly parental worry and helplessness around their child‘s physical and emotional pain, 
as they watch the gradual deterioration, and are faced with difficult-to-answer questions from 
the child about the illness and death (7, 16, 17).  
Socio-demographic predictors of distress in carers 
Several studies suggest that mothers experience higher levels of distress and burden of care 
than fathers (2, 6). This can partly be attributed to the fact that primary caregivers tend to be 
mothers (3). Indeed most research samples are significantly skewed towards female carers 
(1, 3-5, 9-11, 14, 15, 19), with one study (19) comprising of 81 mothers and just four fathers, 
while another (11) only comprised of mothers. The skewed samples pose a significant 
limitation to the generalisability of results and limit the reliability of gender as a predictor of 
distress.  
Other studies suggest that fathers find the time of diagnosis harder than mothers (8, 16), 
however, these conclusions are often drawn from female-skewed samples. Chen et al. (2002) 
found that mothers showed higher stress, conflict, and help needs than fathers, who in turn, 
had higher needs for information and help from resources. 
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Bach et al. (2003) suggest that a parental relationship to the affected child may lessen the 
perception of burden and effort in caring (contrary to that of a nurse), but QoL was still 
perceived to be low. Accordingly, low family support and high family conflict have been 
linked to higher distress (14). 
Other factors linked to distress or high burden of care included being a carer under the age of 
48 (5), income level, religious commitment, education and employment (2, 19), whereas 
other studies (8, 11, 14) found no significant relationship between socio-demographic 
variables and distress. Overall, there seems to be little consistency in what socio-demographic 
factors relate to distress in carers and study limitations, such as gender ratios, sample sizes, 
and absence of optimal controls, pose constraints to interpretation. 
Psychological predictors of distress in carers 
Several studies have attempted to make links between distress and psychological factors. For 
example, Im et al. (2010) found that depressed carers had significantly lower QoL, while 
Holroyd and Guthrie (1986) found that expressing negative feelings about the child 
contributed to parental stress.  
Nereo et al. (2003) found that child behaviour problems were linked to maternal stress, a 
‗dysfunctional‘ parent-child relationship, and perceiving the child as ‗difficult‘. They also 
showed that over two years, maternal stress decreased in relation to perceiving the child as 
‗difficult‘, suggesting that mothers learned to adjust and cope with their child‘s worsening 
symptoms. The study did not investigate additional variables influencing stress, such as 
support services. However these results suggest that adjustment and coping may be more 
important factors in predicting stress than illness severity. Nevertheless, this study did not 
find higher overall stress compared to the normative sample. Similarly, despite significantly 
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lower physical and psychosocial HRQoL in MD children, parental stress was not found to be 
significantly higher than a normative sample (10). 
Several studies provide evidence in support of adjustment and grief as psychological factors 
influencing distress (1, 3, 7, 9, 12, 14, 16, 17). Thompson et al. (1992) found that 57% of 
parents fitted criteria for poor adjustment. Poor adjustment correlated significantly with 
depression, anxiety, stress, and poor coping. Moreover, they found that parental stress, 
depression, and anxiety accounted for 58% of the variance in general distress, 50% in 
depressive symptoms, and 31% in anxiety symptoms. 
In support of the above findings other studies found that, anxiety (5), poor social functioning 
(5, 15), poor parental emotional health (18), negative emotions, and lower vitality (15) 
contributed to higher stress levels as compared to controls. Other contributors were 
pessimism around long-term outcomes and constant awareness that the illness is terminal, as 
well as perceiving insufficient support (18). 
However, these findings must be interpreted with caution due to design limitations already 
addressed, such as gender-skewed and small sample sizes, a limited list of variables explored, 
and the samples often comprising of one MD type, so findings may not necessarily generalise 
to other MD conditions. 
Positive aspects of care-giving and coping 
Despite the focus of this review on distress, several studies surfaced the positive aspects of 
care-giving and adaptive coping (1, 2, 6, 9, 11, 12, 17). For example, although parents of 
children with SMA reported that life was ‗hard‘ significantly more than controls did, their 
reported QoL was no lower than that of controls (6). Nereo et al. (2003) found no 
significance differences in maternal distress in a DMD group compared to their siblings, a 
cerebral palsy group, or a normative sample. 
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Chen et al. (2002) found that DMD carers reported four times less stress than parents of a 
child with fever, and used different coping strategies, including wish-fulfilling fantasy, 
focusing on the present, normalising, and capitalising on personal strengths. 
Some explorative studies found that the emerging themes from carers‘ experiences are about 
personal growth, enrichment, and hope (1, 9, 12, 17). Gradual adjustment follows the initial 
grief reaction, enabling parents to develop positive, realistic, and proactive coping strategies, 
and fulfil more of their child and family‘s potential (1). A mutually dependent and nurturing 
relationship between parent and child inspired the parents to improve family QoL by focusing 
on positive aspects of life, living in the present, and seeing themselves as the child‘s ‗lifeline‘  
(9). 
Two studies (Samson et al., 2009; Gagliardi 1991) have mapped out the carers‘ journey from 
loss to enrichment and hope. With the loss of a healthy child comes disillusionment and grief. 
Carers then move towards achieving a family equilibrium and adapting to challenges over the 
illness trajectory, to the eventual resolution of a new, meaningful life and the rediscovery of 
their child‘s identity. For these families the illness arrives as an external threat alongside hope 
for a miraculous cure until it becomes a part of the child through the struggles of adjustment, 
and hope rests in the present successful coping. Eventually, the illness becomes an integral 
and valued part of the child‘s identity and hope lies within the child‘s individuality. 
Although the sample sizes in these studies are small, they provide a valuable starting point for 
further exploration of these aspects of caring. 
Qualitative versus Quantitative studies 
As expected, qualitative studies provided ‗richer‘ data than quantitative studies, but are 
however less generalisable due to smaller sample sizes and limited types of MD in the 
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samples. However, as illustrated above the main themes from these two types of approaches 
seem to overlap considerably. 
Still, qualitative studies may have presented a more positive view of care-giving than 
quantitative studies, as they afforded the flexibility of exploring care-giving experiences 
widely, rather than only looking for specific variables related to distress. This is important to 
note, as the research in this area seems to still be mapping care-givers‘ experiences and 
clearly indicates that they do not solely concern distress or negative experiences but greatly 
enriching ones as well. 
 
Discussion 
This review aimed to address questions relating to the degree and nature of distress 
experienced by carers of people with MD, the impact on different aspects of life, possible 
psychosocial factors related to distress, and the implications of distress on the populations 
and services involved.  
While the results do not exhaustively address these questions, they present a rich and 
meaningful starting point from which further research can begin to pick up and follow the 
strands comprising the experiences of these carers. 
Degree and nature of distress 
The review involved a number of qualitative and quantitative studies, using a range of 
approaches, designs, and measures. As a result, quantifying distress in carers of people with 
MD poses a challenge. Nevertheless, the studies clearly identify clinical distress levels in this 
population through the use of various measures (4, 5, 14, 15, 18, 19). 
The nature of the distress experienced seems to consist of recurring loss and subsequent 
unresolved grief. Grief-related emotions usually surface at times of change in the progressive 
44 
 
trajectory of the illness, calling for the carers and families to adjust and manage the increased 
burden of care (3, 7, 9, 12, 14, 16, 17). The resulting pattern seems to be one of cycles of loss 
and disarray followed by coping and redefining adversity until the next loss occurs (3). 
Affected aspects of life 
The review revealed that the psychological distress experienced affected all areas of life. For 
instance, Duger et al. (2003) found that the higher the child‘s dependency the higher the 
severity of maternal back pain. Many studies found that carers feel socially isolated (7, 14, 
18) or have self-imposed social boundaries around the family unit which lead to social 
dysfunction (9, 17). Family conflict and marital problems are also present, as are financial 
strains (e.g. 9, 16). In fact, several studies found that these carers have significantly lower 
QoL than controls (5, 15, 19). 
Factors linked to distress 
The reviewed studies attempted to identify the factors explaining variability in carer distress 
scores and these can be grouped into socio-demographic and psychological factors. The 
evidence emerging is mixed and inconclusive with regards to these factors and study design 
limitations restrict generalisability.  
Nonetheless, the main socio-demographic factors that seem to be related to higher distress 
are: female carers (2, 6); low family support and high family conflict (14), young carer age 
(5), lower education, and unemployment (19). Furthermore, the main psychological factors 
seem to be poor carer emotional well-being in terms of mood, anxiety, and adjustment (5, 14, 
15, 18, 19), and child behaviour and socialisation problems (8, 11, 12).   
Positive aspects and coping 
Several studies uncovered the issues beyond distress, with carers describing well-adjusted, 
meaningful lives and an ability to adequately and positively cope with recurring changes (1, 
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9, 12, 17). These parents map out their personal adjustment and transformation alongside the 
illness progression. Their hopes and attitudes towards the illness and the child evolve, just as 
the child evolves and becomes a unique individual. Cohen and Lazarus (1979) support the 
idea that cognitive appraisal of a source of stress is dynamic and since hope emerges through 
cognitive appraisal, hope is also dynamic (DuFault & Martocchio, 1985). Carers are clearly 
able to look ‗beyond the loss‘ and distress to redefine and rediscover their life and their child, 
using hope as an inner resource (12). 
The findings of the review are in line with the wider literature on carers of chronically-ill 
children, in terms of the nature of distress experienced and the impact on carers‘ emotional, 
family, and social worlds (e.g. McGrath, 2001; Carnevale et al., 2006). This review suggests 
that carers of children with progressive MD will face psychosocial demands throughout the 
illness, which can however be managed and overcome, as well as at transitional points 
between stages of progression which are experienced as crises. These findings fit well with 
Rolland‘s (1987) conceptualisation of three stages of psychosocial demands: (1) the crisis, (2) 
the chronic, and (3) the terminal stages. The findings can also be understood in the context of 
Rolland‘s (1987) five elements affecting psychosocial demands which relate to the nature of 
the illness (Table 1). MD disorders are progressive in nature with a high impact on physical, 
mental, and cognitive health, and despite high predictability of the rate of progression, this 
comes with a poor prognosis and often a fatal outcome. Unsurprisingly, for the parents who 
take on a carer role these elements of the disease can be devastating. The literature, however, 
offers a positive take to these carers‘ experiences through their reports of hope and 
enrichment in their lives. 
Literature quality and Future Research 
Although the findings are valuable and interesting, several limitations in the studies stand out 
which may limit their reliability and validity. In line with Polakoff et al.‘s (1998) findings, 
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sample sizes in some of the quantitative studies in this area have been small. Although this 
may be attributed to the rareness of the disorders, the findings need to be replicated with 
larger samples. Moreover, some studies did not use a control group, or used a non-matched 
control by comparing to measure norms, which involve non-disabled healthy children and too 
many variables are perhaps different. 
The samples primarily comprised of carers for boys with DMD and further research needs to 
recruit a range of other MD disorders to allow for greater generalisability of findings. 
Moreover, the carer samples were skewed towards female carers and the views of male carers 
were under-represented in many studies and need to be explored in future research.  
Furthermore, the majority of studies used a cross-sectional (often retrospective) design, 
although three studies (3, 11, 17) collected data at multiple time-points. More longitudinal 
studies are required to add validity to the findings, particularly in relation to how distress and 
adjustment change throughout the illness journey. Additionally, since any list of factors 
influencing distress is unlikely to be exhaustive, further research needs to replicate the results 
of studies identifying predictors and continue to explore further possibilities, with the aim of 
untangling the influence of socio-demographic and psychological factors influencing distress 
in carers.  
Finally, one must wonder if the nature of qualitative studies brings about issues of social 
desirability which make it harder for parents to express distress in caring for their child, 
especially since home-based care is becoming a social expectation. Still, although better 
controlled quantitative studies can be conducted, the richness in explorative studies may be 
indicative of research in the area still lying in its early stages. The findings from these studies 
need to be further explored and understood using a firmer conceptual framework around 
chronic, genetic illnesses (such as that proposed by Street & Soldan, 1998). 
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Conclusions and Implications 
It is clear that caring for a person with MD can be a distressing and challenging experience. 
This is particularly the case if the carer has a familial relationship with the person, since the 
caring context becomes the entire family. This inevitably broadens the experience and impact 
of caring onto the family unit. Despite the undeniably strenuous (emotionally, physically, and 
socially) experience for carers, patients and their families, caring nevertheless also offers 
opportunities for growth and enrichment. 
The distress experienced by carers impacts on their ability to provide care and subsequently 
impacts on patient QoL, their experiences, and personal growth. As care for people with 
chronic conditions moves largely to the home environment (Boström et al., 2006) support for 
the carers will directly influence the quality of care for the patient (e.g. Im et al., 2010). It is 
clear that services need to consider carers and their families‘ emotional well being in care 
plans and offer psychological support at points of crisis, as well as practical help and advice. 
Carers need to be brought together to enable a sense of belonging, understanding, and 
support. Through mutual advice-sharing these carers can feel empowered and in control as 
has been repeatedly reported by carers joining support groups (1, 9, 12, 17).  
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ABSTRACT 
Objectives: DMD is a life-limiting condition affecting the muscles. Cognitive deficits in areas 
of memory have been consistently found in children with DMD. Their life expectancy has 
been extended by Non-invasive Positive Pressure Ventilation (NIPPV) which is administered 
when hypoventilation develops. However, little is known about the cognitive profile of this 
older DMD population and the effects of hypoventilation and NIPPV on cognition.  
Method: Two groups with advanced DMD were recruited. The boys in the Duchenne 
Muscular Dystrophy Ventilated (DMDV) group (N=17) were on NIPPV while the boys in the 
Duchenne Muscular Dystrophy Control (DMDC) group (N=16) did not need NIPPV. Both 
groups were tested on memory, executive function, mood, quality of life (QoL), and beliefs 
about sleep. Results: The groups were compared on performance on each measure. No 
significant differences were found on any of the measures. The performance of the whole 
sample revealed differences between verbal and visual memory, as well as between list recall 
and story recall. Conclusions: Hypoventilation does not seem to lead to permanent cognitive 
deficits in advanced DMD subjects. Moreover, verbal capacity span may remain limited in 
this population as was found in studies of younger samples. Implications and suggestions for 
future research are discussed. 
 
 
 
 
 
 
 
 
60 
 
INTRODUCTION 
Duchenne Muscular Dystrophy (DMD) 
DMD is an inherited, progressive muscular disorder, predominantly affecting boys. It is 
caused by a gene mutation where the defective gene hampers the production of dystrophin, a 
crucial protein for the muscle fibres and the central nervous system. [1, 2] Lack of this 
protein leads to a progressive weakening and degeneration of the muscles which results in a 
significantly reduced life expectancy. [3]  
DMD is rare, with prevalence in the general population of about one in every 3,500 male 
births [4], yet it is one of the most severe and common forms of progressive muscular 
disorder. 
Cognition in DMD 
Based on a meta-analysis, general intellectual functioning was found to be normatively 
distributed but shifted downwards by approximately 1 standard deviation, (mean Full Scale 
IQ = 80.2 (SD = 19.3)) [5]. Other studies [3,6,7] however, have found general intellect to be 
within the normal range and support the presence of a specific deficit in verbal working 
memory, affecting verbal span capacity but not recall [2]. For example, Wicksell et al. [7] 
used the Ravens Matrices, instead of the Wechsler Intelligence Scales which require the use 
of short-term memory already established to be impaired in this population [3, 6], and found 
intellect is in the normal range. Hinton et al. [2] maintain that lower IQ scores found in past 
studies may reflect the fact that ―missing dystrophin…may make it harder to process large 
verbal loads‖ (p.127), for instance the structured administration guidelines which do not 
allow the repetition of instructions. 
Hinton et al. [2, 3, 6, 8] have completed a series of studies which support the presence of a 
specific cognitive profile in the DMD population characterised by lower verbal IQ, poor 
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attention to complex auditory material and specific deficits in immediate verbal memory and 
verbal processing. The authors hypothesise that immediate verbal working memory may 
become taxed more readily in boys with DMD, and refer to Baddeley et al.‘s [9] 
―phonological loop‖, responsible for acquiring, rehearsing and consolidating information. 
They suggest that this loop is limited in children with DMD and thus less information can be 
processed once heard than that normally expected. 
The literature appears to generally agree on the presenting deficits around verbal working 
memory (i.e. limited verbal span) which may have potential implications in academic 
achievement and social integration (Hinton et al., 2007). [2] However, a recent study by 
Donders and Taneja ([10]; p.302) argues for ‗…neurobehavioral impairments, affecting 
verbal and nonverbal cognitive domains, as well as some aspects of psychosocial and meta-
cognitive abilities‘. It is therefore clear that a definitive cognitive profile for children with 
DMD is still a matter of debate and further research. [10] 
 Cotton et al. argue that, while most studies focus on verbal and language development in 
children with DMD, non-verbal intelligence remains largely unstudied. [5] This is 
particularly true for studies of executive function. [10] 
Hypoventilation in DMD 
Respiratory problems are almost inevitable as the weakening of the muscles around the 
breathing apparatus causes them to fail. Problems first become evident during sleep and 
eventually lead to hypoventilation and hypoxic episodes. [11] In DMD lack of dystrophin has 
been shown to render specific neuronal populations susceptible to hypoxic insults, 
particularly the hippocampus [12] and cerebellum [13], which could potentially contribute to 
the development of cognitive deficits. 
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Hypoventilation can also cause daytime sleepiness, reduced quality of life (QoL) and social 
functioning, and impaired cognitive performance. [14] The effects of hypoventilation on 
cognition have been studied in conditions such as amyotrophic lateral sclerosis [15] but not in 
DMD. These studies have shown that sleep-disordered breathing can lead to specific 
cognitive deficits, such as memory and executive functioning difficulties. [12] 
 Treatment with nocturnal ventilation 
It has been shown in different medical conditions that many of the effects of hypoventilation 
can be effectively reversed with Non-Invasive Positive Pressure Ventilation (NIPPV) – a 
generally nocturnal supply of oxygen which treats hypoventilation. [14-16] Specifically 
quality of sleep, QoL, and cognitive performance have been shown to improve while daytime 
sleepiness reduces. [14] 
Moreover, research has shown that NIPPV significantly extends the life expectancy of DMD 
sufferers as hypoxic episodes are reduced or even eliminated for an extended period of time. 
[4, 17] The increase in life expectancy has given rise to an emerging and unforeseen 
population of late-stage DMD sufferers well into their twenties. [18]  
There is no definite evidence on how the cognitive profile of this population changes over the 
years, i.e. whether cognitive deficits seen in the younger population remain the same, worsen, 
or improve, and whether any further cognitive deficits develop. Studies have suggested a 
cumulative deterioration of academic achievement and social functioning, as the deficits 
impair development [7] while others present evidence that deficits reduce with age. [5, 19] 
Moreover, even less is known around the effects of hypoventilation on cognition in advanced 
DMD and the effects of nocturnal ventilation on cognition. 
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Attitudes and beliefs about sleep 
Smith et al. found a high prevalence of insomnia in people with hypoventilation, and also 
found that these individuals express dysfunctional beliefs about sleep. [20] It has been found 
that dysfunctional beliefs about sleep, such as ‗there is little one can do about poor sleep‘, 
may underlie and perpetuate anxiety about, and difficulties with sleep in people with sleep 
problems. [21-23]  
In a study of primary insomniacs, Edinger et al. found that ‗CBT is effective for reducing 
dysfunctional beliefs about sleep‘ as compared to controls who received treatment as usual. 
[24] 
It is therefore, important to consider whether dysfunctional beliefs about sleep can be 
observed in the DMD population similar to those found in other populations with sleep 
difficulties, and if so then DMD sufferers may also benefit from CBT focusing on sleep. 
 Gaps in literature and rationale for study 
As Rahbek et al. note ‗knowledge of adult life with DMD is sparse‘ (p.17). [18] The 
cognitive profile of advanced DMD remains speculative based on that of the younger 
population. Moreover, the effects of hypoventilation on cognition and the extent of their 
reversibility with ventilation treatment in this population remain unknown. Additionally, the 
attitudes about sleep held by DMD patients with hypoventilation, who suffer from poor 
quality and quantity of sleep, are unknown.  
Research Questions 
1. What is the cognitive profile of advanced DMD (specifically visual/verbal memory and 
executive functioning)? 
2. Do hypoxic episodes result in specific cognitive deficits which are not reversible by 
NIPPV (specifically visual/verbal memory and executive functioning)? 
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3. Do QoL, mood (depression and anxiety), daytime sleepiness and beliefs about sleep differ 
between ventilated and non-ventilated DMD sufferers (and do they improve following 
ventilation treatment)? 
Methodology 
Two DMD groups were used; Duchenne Muscular Dystrophy – Ventilated (DMDV) 
comprised of boys with hypoventilation on NIPPV treatment, and Duchenne Muscular 
Dystrophy – Control (DMDC) comprised of boys who had not yet developed such 
difficulties. Both groups underwent neuropsychological testing and completed measures of 
sleepiness, mood, beliefs about sleep, and QoL. 
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METHOD 
Ethical approval was obtained from the South Humber Ethics Committee before the 
commencement of the study (Appendix O). 
Design 
This cross-sectional study investigates differences in cognitive abilities, mood, sleepiness, 
QoL, and beliefs about sleep of boys with DMD at two time-points of the illness; before 
hypoventilation (DMDC, N=16) and during treatment for hypoventilation (DMDV, N=17).  
 Participants 
Participants were English native speakers with a diagnosis of DMD, over the age of 16. Due 
to the limited research in the advanced DMD population, power calculations were conducted 
on the basis of previous literature with other relatively rare neurodegenerative disorders. 
Specifically, Newsom-Davis et al. (2001) investigated the effects of NIPPV on cognition in 
people with Amytrophic Lateral Sclerosis and used nine participants for the experimental 
group and ten for the control group. [15] Given the cross-sectional design an approximate 
doubling of those figures was aimed for recruitment.  
Participants were identified by their healthcare teams using inclusion/exclusion criteria 
(Appendix K) during routine procedures or via their medical files. Routine medical practice 
involves an assessment of DMD patients in relation to signs of hypoventilation every 6 
months. Forced lung capacity measurements are taken to determine if NIPPV is needed. 
Participants in the DMDV group were identified by healthcare staff as those already on 
NIPPV treatment. Participants in the DMDC group were identified either during their routine 
assessment or via their notes as patients not anticipated requiring NIPPV in the next 6 
months.  
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Recruitment was carried out from three national centres for neuromuscular disorders, namely; 
The Newcastle Muscle Centre, the Neurology department at Leeds General Infirmary, and 
Treloar College in Surrey.  
Measures 
Psychometric measures for verbal and visual memory were selected since most deficits 
reported in DMD literature involve memory skills, as well as tests to measure executive 
function skills since these have not been previously well studied. The tests and the cognitive 
areas they target are listed in Table 1 and detailed information can be found in Appendix L. 
Table 1.   Psychometric measures used and the corresponding cognitive areas tested. 
Test Subtest Cognitive area tested 
Adult Memory & Information 
Processing Battery (AMIPB) 
[25] 
List learning 
Story recall 
Verbal recall (without and 
with context) 
Digit Span (DS) 
Researcher-created based on 
the Wechsler Adult 
Intelligence Scale-III 
Working Memory 
Doors and People [26] 
Doors test 
Names test 
Visual recognition 
Verbal recognition 
Delis and Kaplan Executive 
Function System (D-KEFS) 
[27] 
Colour-Word Interference test 
Sorting test (Recognition) 
Twenty Questions test 
Executive function: 
Problem solving, 
cognitive set shifting, 
attention, categorising, 
organizing 
Ravens Standard Progressive 
Matrices [28] 
- 
Logical reasoning and 
current intellectual 
functioning 
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Questionnaires 
The Epworth Sleepiness Scale [29] and the Short-Form 36 health survey [30], widely used in 
hypoventilation literature, were administered. Moreover, the Hospital Anxiety and 
Depression Scale [31] was selected as an established, standardized measure of mood. 
Previous studies using the HADS with physically disabled individuals have omitted the item 
‗I feel as if I have slowed down’ [15] so as to avoid an artificial rise in scores. This was not 
done in this study as the aim was to consider differences between groups, and not scores 
relating to the generic measure norms. Finally, the abbreviated version of the Dysfunctional 
Beliefs and Attitudes about Sleep (DBAS) scale [32] was used as a validated measure of 
beliefs about sleep. 
Procedure 
Candidates identified by the healthcare team were given the information sheet and consent 
form (Appendices M & N) and were asked to consent for their contact number to be provided 
to the researcher. The researcher then contacted the participants by phone to discuss the 
research in detail and formal consent was obtained. 
An appointment was arranged and all the questionnaires were sent out by post to be 
completed prior to the appointment. The psychometric measures were administered during 
the appointment over an average of one hour and thirty minutes.  
All the participants were seen at their residence due to the complexities of transportation. 
Hypotheses(a) There will be no significant differences between the DMDV and DMDC 
groups on measures of sleepiness, mood, beliefs about sleep, or QoL. 
(b) There will be no differences in general intellectual ability between the two groups. 
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(c) The DMDV group will perform worse on measures of executive function and memory 
than the DMDC group due to irreversible cognitive deficits caused by hypoxic episodes prior 
to NIPPV commencement. 
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RESULTS 
Participants 
All patients meeting the inclusion criteria were invited to take part in the study. Sixteen 
participants consented from Leeds, eleven from Newcastle, and six from Treloar College. 
Table 2 shows the groups‘ main characteristics. Comparisons between groups on 
demographic variables using Pearson Chi-squared tests (and Mann-Whitney for the age 
variable) revealed that the DMDV group was significantly older and had higher education, 
with most participants stating ‗unemployed‘, whereas in the DMDC group most participants 
were still in education. 
Table 2. Demographic information and comparisons of DMDC and DMDV groups 
Demographic variable DMDC (N=16) DMDV (N=17) 
Statistical differences 
(p value) 
Age 18.81 (2.74) 22.24 (4.01) .01
*
 
Education (highest level completed) .012
*
 
Primary school 0 1  
Secondary School 13 6  
College 3 5  
University 0 5  
Living arrangements 
Living with 2 parents 13 12 
.840 Living with 1 parent 2 2 
Living alone 1 3 
Living with 1 sibling 7 3 
.198 Living with >1 sibling 2 6 
Not living with siblings 7 8 
Occupation .011
*
 
Employed 0 1  
Unemployed 3 10  
In education 13 5  
Other 0 1  
Age is reported as mean (standard deviation). Remaining variables are reported as frequencies. 
* p < 0.05 
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Analyses 
 Questionnaires 
Table 3 gives a summary of the mean (standard deviation) on each questionnaire 
administered for each group, and the p value of statistical differences between groups. No 
significant differences were found. ESS approached significance in the expected direction of 
DMDC scoring higher.  
Table 3. Mean (SD) score and statistical significance of differences between the DMDC and 
DMDV groups on ESS, DBAS, HADS, and SF-36. 
Questionnaire DMDC (N=16) DMDV (N=17) 
Statistical differences 
(p value) 
ESS 3.38 (.87) 1.82 (.58) .072 
DBAS 3.45 (.40) 3.40 (.41) .866 
HADS – Depression 5.00 (.65) 3.71 (.47) .139 
HADS – Anxiety 3.06 (.39) 2.76 (.53) .462 
SF-36 
Physical functioning 16.63 (3.73) 15.44 (.70) .488 
Role of physical 
functioning 
51.38 (6.70) 47.92 (10.07) .402 
Bodily pain 54.32 (5.47) 52.90 (8.26) .557 
General health 44.48 (6.38) 41.31 (9.08) .557 
Vitality 56.15 (6.81) 55.18 (9.32) .901 
Social functioning 51.37 (7.54) 51.71 (8.58) .845 
Role of emotional 
functioning 
50.73 (8.57) 52.24 (8.94) .581 
Mental health 50.44 (7.64) 50.18 (10.22) .736 
Physical Component Score 36.26 (3.21) 33.03 (5.70) .127 
Mental Component Score 59.52 (7.26) 60.80 (9.16) .444 
 * p < 0.05 
Psychometric tests 
One participant from the control group did not complete the psychometric testing, while 
another completed only the digit span and Doors and People tests.  
71 
 
All the psychometric measures were compared between groups using exact Mann-Whitney 
tests. Effect sizes, if present, were not expected to be large given the small sample sizes, 
therefore no correction for multiple statistical tests was applied. 
Table 4 shows the mean (standard deviation) of each group on each measure and the p values 
obtained. No significant differences were found between the control and experimental group 
in any of the tests.  
Table 4. Mean (SD) and significance of differences between the DMDC and DMDV groups 
on the psychometric measures. 
Measure DMDC (N=14) DMDV (N=17) 
Statistical 
differences (p value) 
Ravens Standard Progressive 
Matrices 
38.07 (9.24) 38.18 (7.22) .953 
Digit Span 7.93 (1.44)
a
 9 (2.60) .455 
Doors and People 
Doors test 16.93 (3.45)
a
 15.82 (3.73) .502 
Names test 19.73 (2.52)
a
 21.18 (1.51) .114 
AMIPB 
List Learning 
            List A1-A5 45.93 (7.04) 46.06 (10.61) .953 
            List A6 9.43 (3.78) 10.71 (2.89) .468 
Story Recall 
           Immediate Recall 22.00 (12.61) 20.18 (8.89) .769 
          Delayed Recall 19.36 (12.21) 17.59 (9.29) .830 
D-KEFS 
Colour-Word Interference 
          Condition 1 39.36 (8.57) 39.47 (8.75) .468 
          Condition 2 28.29 (7.47) 27.71 (4.41) 1.00 
          Condition 3 71.43 (21.11) 76.18 (31.25) .769 
          Condition 4 74.43 (23.91) 76.76 (21.37) .653 
Sorting (Recognition) 21.93 (10.77) 22.35 (10.61) .860 
Twenty Questions 
          Initial Abstraction 28.79 (4.84) 26.81 (9.48) .951 
          No. of questions 27.07 (7.36) 30.71 (12.16) .681 
          Weighted Achievement 15.36 (3.63) 14.18 (3.50) .597 
* p < 0.05 
a 
N=15 for DMDC group 
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Overall sample performance 
An investigation of each group‘s performance in relation to the measure cut-off points for 
deficits (i.e. how many participants in each group scored below the 2% cut-off for 
impairment on the measure based upon data from the normative sample) was carried out to 
determine how many subjects scored at the cut-off, providing thus a generic cognitive profile 
for this population (Table 5). The results suggest that both groups had relatively high 
numbers scoring on or below cut-off. Moreover, the number of subjects below cut-off seems 
to be higher overall in the DMDV group, particularly on List Learning (A1-A5), Story 
Recall, and Conditions 1 and 3 of the Colour-Word Interference test. Nevertheless, the mean 
scores for each test obtained by each group were all above the clinical cut-offs, with the 
exception of the Ravens matrices where both groups scored below the 5
th
 percentile. 
Table 5. Number of participants in DMDC (N=14) and DMDV (N=17) groups that are on or 
below the cut-off scores for each measure used.  
Measure 
Number in DMDC on or 
below cut-off (N=14) 
Number in DMDV on or 
below cut-off (N=17) 
Digit Span 10* 10 
Doors & People 
Doors Test 2* 5 
Names Test 1* 0 
AMIPB 
List Learning (A1-A5) 3 7 
List Learning (A6) 3 5 
Story Recall (Immediate) 4 7 
Story Recall (Delayed) 5 7 
DKEFS 
Colour-Word Interference 
      Condition 1 5 8 
      Condition 2 3 6 
      Condition 3 7 8 
      Condition 4 5 5 
Sorting 
      Card Sets 1 & 2 2 4 
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      Card Sets 3 & 4 1 4 
Twenty Questions 
      Initial Abstraction Score 0 0 
     Total no. of questions asked 1 3 
     Weighted Achievement Score 2 1 
* N=15 
The data from each group was combined (N=34) given the absence of significant differences 
on measures between the groups to further explore a likely cognitive profile for advanced 
DMD.  
A paired-samples t-test was used to compare the group‘s performance on visual and verbal 
recognition memory (Doors Vs Names test). The difference was statistically significant (t = -
5.25, p < .000), indicating a higher performance in verbal rather than visual memory. 
Scores were converted to percentages and comparisons were also made between recall 
conditions (AMIPB) and digit span. No notable differences between immediate and delayed 
recall (Story Recall) were found. However, performance on digit span and List Learning were 
higher than in Story Recall.  
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DISCUSSION 
This study aimed to provide a cognitive profile of advanced DMD and identify any 
permanent cognitive deficits following hypoventilation in individuals receiving NIPPV 
treatment. The subjects recruited were considerably older as compared to most studies of 
DMD investigating cognitive abilities. [2, 3, 6-8, 10] Previous studies typically involved 
DMD subjects aged between 6-16 years old, whereas the current study involved subjects aged 
16 years and over. Measures of memory, executive function, and overall intellectual ability 
were taken, along with measures of sleepiness, beliefs about sleep, mood, and QoL. 
The results of the study indicate no permanent cognitive deficits resulting from 
hypoventilation, since no differences were found on any of the measures between the 
ventilated and the control group. This is contrary to literature warning that lack of dystrophin 
leaves hippocampal and cerebellar neuronal populations vulnerable to hypoxic damage. [12, 
13] 
However, it remains a possibility that during hypoventilation cognitive deficits do develop 
and are later reversed by NIPPV treatment, as has been found in other conditions. [14, 15]  
Demographics and Questionnaires 
Despite some variability in family composition ranging from single parents to couples and 
living independently, and from no siblings, to one or more siblings, it appears that most DMD 
boys in the advanced stages live with two parents, as there were no differences between the 
groups. This suggests that family units are maintained even during this difficult stage, 
contrary to literature on family breakdown in other childhood terminal illnesses. [33] 
The only questionnaire approaching significance was the ESS, where controls tended to score 
higher than ventilated boys. This is to be expected as the ventilated group are receiving 
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treatment that has been shown to reduce sleeplessness in other conditions and the controls are 
possibly beginning to move towards hypoventilation.  
Despite possible issues with using the HADS in a population with physical disabilities [15] 
both groups scored well below the measure‘s cut-off for depression and anxiety. 
DMD boys seem not to hold dysfunctional beliefs about sleep, contrary to the literature that 
suggests sleeplessness is a central issue in the illness journey. [20-22] Moreover, in line with 
other literature QoL seems not be affected by the use of NIPPV since the groups reported 
comparable QoL on the SF-36. [34] This is further supported by the comparable, and indeed 
low scores in anxiety and depression. 
Psychometrics 
The literature on cognitive abilities and DMD has largely focussed on people under 16 years 
old. It is thus unknown whether these individuals maintain the abilities outlined by the 
literature throughout their life, or if these change. Evidence around this issue is mixed, with 
some suggesting a further deterioration [7], while others point to an improvement in deficits. 
[5, 19]  
The data was considered in relation to clinical cut-off scores for each measure. Notably the 
experimental group showed a higher number of participants below cut-off for most of the 
measures, but both groups‘ means were above clinical cut-offs. The Ravens matrices was 
used as a measure of general intellectual ability and although this is a validated alternative to 
IQ tests it must be used with caution. The sample scored below clinical cut-off on this test. 
This result was taken as possibly indicative of a specific developed deficit in visuospatial 
ability, as opposed to a deficit in intellectual ability, since the sample‘s performance on all 
the other tests was above clinical cut-off. 
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Given the absence of significant differences between the groups, the data was merged to 
create a larger sample of advanced DMD patients from which a preliminary cognitive profile 
could be drawn. Performance between different measures was considered, indicating that 
verbal recognition was stronger than visual recognition. This was a surprising result given the 
extensive literature supporting verbal memory deficits. [2, 3, 6, 8]  
However, when considering verbal recall it appears that the participants scored higher on list 
learning than story recall, which is in support of literature positing a specific verbal deficit 
affecting verbal capacity span in DMD children. [6] It is possible the story ‗overloaded‘ the 
auditory processing capabilities of the participants‘ ‗phonologic loop‘, contrary to the less 
complex and repeated exposure of the list learning. [9] Performance on Story Recall also 
seemed poorer to digit span performance, indicating perhaps a slower processing speed of the 
story information than of the numbers, possibly due to a limited phonologic loop capacity. 
Nevertheless, design limitations in this study require that these observations are explored 
further in studies with larger samples to determine the effect sizes of any replicated results. 
Limitations and future research 
The study applied a cross-sectional design which limits the conclusions that can be drawn on 
the basis of causality. Furthermore, sample sizes for the two groups were relatively small, 
limiting thus the statistical analyses possible as well as the power of the study. These 
limitations are typical of studies in DMD and call for larger longitudinal studies. [35] 
Moreover, demographic comparisons revealed significant differences between the groups on 
age, education, and occupation. Although all the subjects were over the age of 16, the control 
group was significantly younger, and thus still in education. However, an older ventilated 
group is reasonable since hypoventilation becomes more likely with age, and although 
differences in age may influence cognitive performance the measures used either 
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encompassed the whole age range within the same group for scaled scores, or the scaled 
scores were identical or overlapping between age groups.  
Future studies should further investigate the abilities tested by the Ravens matrices in older 
DMD populations to determine why the sample scored selectively low on this test in relation 
to the other measures and investigate the possibility of a developing specific deficit. 
A more informative study could involve larger samples of controls and boys who are about to 
start on NIPPV, tested on cognitive functioning and retested following a period of NIPPV 
treatment in the experimental group (and treatment as usual for the control group). Such a 
design would address the question of not only whether cognitive abilities decline during 
hypoventilation, but also how far those deficits are reversible by NIPPV. This will in turn 
provide further evidence on the role of dystrophin in the brain, but more importantly will 
allow services to proactively support families in how to incorporate the presence of cognitive 
deficits in the care they provide (during or after hypoventilation). 
Conclusions 
This study suggests that hypoventilation during advanced DMD does not result in any 
permanent cognitive deficits. This may be attributed to well-designed services that monitor 
and efficiently respond to the changing needs of DMD patients, establishing NIPPV 
treatment soon after hypoventilation develops, thereby limiting the occurrence of hypoxic 
episodes.  
However, the possibility of reversible cognitive deficits during hypoventilation remains an 
open question which needs to be addressed by further investigation. Hypoventilation is a very 
difficult transitional stage in the illness trajectory for both patients and carers, as it signifies a 
marked deterioration in health and significant changes in illness management. Therefore, any 
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behavioural and emotional changes attributable to cognitive decline need to be identified to 
enable an optimal management of this phase by everyone involved. 
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Appendix A 
Reflective Statement 
Embarking on a research journey has been an enriching experience throughout, from the 
initial stages of planning the research and deciding on how to answer the research questions, 
to organising logistical and practical aspects prior to recruitment such as getting forms, 
engaging services, and going through ethical approval, through to carrying out the testing and 
working through the data, until finally write-up and contemplating on the implications of the 
work I produced. 
From theory to practice: letting go of ‘the dream’ 
Designing a well-thought out study can be difficult, but it is only when you achieve this that 
the real challenge is revealed. Materialising a study design is always dictated by the resources 
available to you. I was faced with this reality at all the different stages of my research 
journey, and I soon had to become more realistic about numbers (recruitment), resources 
(time, money, people, motivation), and subsequently the aims of my study. 
Resource limitations are too many to outline, however time is primarily significant 
particularly with regards to initiating and completing the recruitment phase. I felt I was in a 
constant race against time to coordinate all my recruitment centres, complete the logistical 
aspects and motivate the staff I relied upon to recruit my participants, and throughout the 
recruitment stage to maintain that motivation and push for as many participants as possible in 
order to meet my planned numbers. As I watched time run out I was forced to make difficult 
decisions regarding my design, which I then needed to push forward with all the recruitment 
centres, even adding another centre to meet the demands of my new plan. 
Another major resource constraint was the budget. The available money dictated and forced 
changes to my study design, for instance on how far and often I could travel to participants, 
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but particularly around the psychometric tests I was able to choose when planning the study. 
The challenge was to minimise spending while also minimising limitations to the research 
design by ensuring the chosen tests were adequate to answer the research questions.  
While my design adapted to the available resources, be it time or money, stress was building 
up at the thought of my ‗flawed study‘, until I was able to reflect on a philosophical view of 
research: i.e. is there a perfect study? I remembered that in any study there are always areas 
for improvement, and someone will always be able to come up with a better plan or idea, 
however, the bottom line is one can only always work within the limits of their resources and 
abilities. When I felt satisfied with my philosophical exploration I was able to see beyond the 
limitations of the study and acknowledge the importance of what I was exploring as 
something no one had looked at before (irrespective of how ‗un-perfect‘ my way of looking 
at it was). 
Measure selection 
Selecting measures did not simply involve considering what the research questions were and 
how to answer them. Beyond the money measures would cost I also had to consider my 
population and the abilities, limitations, and confounders that may arise with a DMD 
population.  And although sharing thoughts, ideas, and plans with colleagues was invaluable 
in guiding my decisions, I discovered that everyone has an opinion! Sometimes, too many 
heads put together can lead to chaos while clarity can be found in isolation. 
Collaborators 
From the start it was clear that finding the right people to engage would be crucial to 
recruitment and subsequently the entire project. However, it soon became apparent that 
finding the people was only the first step. Beyond keeping everyone up to date with constant 
changes and ensuring they are clear about their role, there were challenges in getting every 
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site ready in time. More crucially, I found myself constantly having to remind and motivate 
collaborators to keep the project in mind and help me recruit throughout. Having to relinquish 
so much control was difficult and stressful to say the least. I literally depended and relied 
upon them for recruitment and the future of the whole project.  
Becoming a chameleon 
A constant demand throughout testing was flexibility and adaptability, not just in terms of 
managing travelling time and cost and trying to organise appointments in as much an efficient 
manner as possible, but also during the testing session itself. Due to the varying physical 
limitations which go hand in hand with DMD participants who can be at different levels of 
agility and mobility, I was faced with a range of testing conditions. Some boys were able to 
sit upright in wheelchairs (with some having an adequate attached table for laying out testing 
material, and others not having a table at all), while others were lying in bed. Being creative 
in order to carry tests through while maintaining standardised testing procedures was a 
challenge.  
To add to this challenge the concerned or simply curious parents sometimes joined in the 
session, pending the participant‘s permission, and I found myself having to maintain a 
humanistic approach to their comments in-between tests while maintaining objectivity and 
standardisation at the same time. Moreover, other challenges of testing people at home 
included noise and disruptions from people coming in and out of the house or even the room. 
What have I learnt then? 
The experiences throughout this journey have been challenging but ultimately rewarding as 
they were overcome and I crossed the finish line. I have learnt valuable lessons which will 
undoubtedly serve me in the future. 
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A key conclusion is that planning and organisation must be at the heart of any research 
endeavour. However, one must also keep in mind that things almost never go exactly as 
planned no matter how well organised you are. It is thus important not to just plan but to also 
have back-up plans and be prepared to adapt to changing circumstances. Change seems to be 
inevitable as too many factors are at play when conducting research that are out of one‘s 
control, including collaborating with people perhaps less motivated to carry the project 
through. 
In terms of research within the field of Muscular Dystrophy (MD), it has become clear that 
longitudinal (and other) research is needed to explore new areas which have opened up 
following progressions in the medical field. However, research with such rare populations 
(even within a DMD population which is the most common of all MD) requires a long 
recruitment period to get satisfactory numbers. Time is of the essence, and even though I 
knew and tried to account for this in my research I was still over-optimistic and 
underestimated how my inclusion/exclusion criteria would narrow even further the small 
recruitment pool I had. Nevertheless, the hurdles I faced have not discouraged me from 
conducting research in this area, instead the challenges have only made me feel more 
passionate about promoting research in this field. 
My experience of conducting a research project was coloured by good and bad moments and 
has left me with an overall drive to do more and do it better in the future. 
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Appendix B 
Author Guidelines for the British Journal of Health Psychology 
Notes for Contributors 
The aim of the British Journal of Health Psychology is to provide a forum for high quality 
research relating to health and illness. The scope of the journal includes all areas of health 
psychology across the life span, ranging from experimental and clinical research on aetiology 
and the management of acute and chronic illness, responses to ill-health, screening and 
medical procedures, to research on health behaviour and psychological aspects of prevention. 
Research carried out at the individual, group and community levels is welcome, and 
submissions concerning clinical applications and interventions are particularly encouraged.  
 
The types of paper invited are: 
 papers reporting original empirical investigations;  
 theoretical papers which may be analyses or commentaries on established theories in 
health psychology, or presentations of theoretical innovations;  
 review papers, which should aim to provide systematic overviews, evaluations 
and interpretations of research in a given field of health psychology; and  
 methodological papers dealing with methodological issues of particular relevance to 
health psychology.  
1. Circulation 
The circulation of the Journal is worldwide. Papers are invited and encouraged from authors 
throughout the world. 
2. Length  
Papers should normally be no more than 5000 words (excluding the abstract, reference list, 
tables and figures), although the Editor retains discretion to publish papers beyond this length 
in cases where the clear and concise expression of the scientific content requires greater 
length. 
3. Editorial policy  
The Journal receives a large volume of papers to review each year, and in order to make the 
process as efficient as possible for authors and editors alike, all papers are initially examined 
by the Editors to ascertain whether the article is suitable for full peer review. In order to 
qualify for full review, papers must meet the following criteria: 
 the content of the paper falls within the scope of the Journal  
 the methods and/or sample size are appropriate for the questions being addressed  
 research with student populations is appropriately justified  
 the word count is within the stated limit for the Journal (i.e. 5000 words)  
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4. Submission and reviewing 
All manuscripts must be submitted via our online peer review system. The Journal operates a 
policy of anonymous peer review. Authors must suggest three reviewers when submitting 
their manuscript, who may or may not be approached by the Associate Editor dealing 
with the paper.  
5. Manuscript requirement 
 Contributions must be typed in double spacing with wide margins. All sheets must be 
numbered.  
 Tables should be typed in double spacing, each on a separate page with a self-
explanatory title. Tables should be comprehensible without reference to the text. They 
should be placed at the end of the manuscript with their approximate locations 
indicated in the text.  
 Figures can be included at the end of the document or attached as separate files, 
carefully labelled in initial capital/lower case lettering with symbols in a form 
consistent with text use. Unnecessary background patterns, lines and shading should 
be avoided. Captions should be listed on a separate sheet. The resolution of digital 
images must be at least 300 dpi.  
 For articles containing original scientific research, a structured abstract of up to 250 
words should be included with the headings: Objectives, Design, Methods, Results, 
Conclusions. Review articles should use these headings: Purpose, Methods, Results, 
Conclusions. Please see the document below for further details: 
British Journal of Health Psychology - Structured Abstracts Information  
 For reference citations, please use APA style. Particular care should be taken to 
ensure that references are accurate and complete. Give all journal titles in full.  
 SI units must be used for all measurements, rounded off to practical values if 
appropriate, with the imperial equivalent in parentheses.  
 In normal circumstances, effect size should be incorporated.  
 Authors are requested to avoid the use of sexist language.  
 Authors are responsible for acquiring written permission to publish lengthy 
quotations, illustrations, etc. for which they do not own copyright.  
For guidelines on editorial style, please consult the APA Publication Manual published by the 
American Psychological Association. 
6. Publication ethics  
All submissions should follow the ethical submission guidelines outlined the the documents 
below:  
Ethical Publishing Principles – A Guideline for Authors  
Code of Ethics and Conduct (2006)  
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7. Supplementary data  
Supplementary data too extensive for publication may be deposited with the British Library 
Document Supply Centre. Such material includes numerical data, computer programs, fuller 
details of case studies and experimental techniques. The material should be submitted to the 
Editor together with the article, for simultaneous refereeing. 
8. Copyright  
On acceptance of a paper submitted to a journal, authors will be requested to sign an 
appropriate assignment of copyright form. To find out more, please see our Copyright 
Information for Authors. 
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Appendix C 
Author Guidelines for Journal of Neurology, Neurosurgery, and Psychiatry 
Papers 
Full papers must present important and substantial new material. Articles should be of direct 
relevance to clinical practise. Thus we do not generally publish research based on animal 
experiments nor studies of normal nervous system function.  
Word count: 3500 words maximum. 
Abstract: 250 words. 
Tables/Illustrations: should not normally exceed 8. 
References: 40.  
Manuscript format (BMJ Group) 
All manuscripts must be submitted via Bench>Press. 
 
All material submitted is assumed to be submitted exclusively to the journal unless the 
contrary is stated. Submissions may be returned to the author for amendment if presented in 
the incorrect format. 
 
If you are submitting a randomised controlled trial, please send with your manuscript the 
following: 
The registration number of the trial and the name of the trial registry - in the last line of the 
paper's structured abstract. Trials that begin enrolment of patients after 1 July 2005 must 
register in a public trials registry at or before the onset of enrolment to be considered for 
publication. Trials that began patient enrolment on or before 1 July 2005 must register before 
13 September 2005 to be considered for publication. Please see the Statement from the 
International Committee of Medical Journal Editors.  
Cover letter 
Your cover letter should inform the Editor of any special considerations regarding your 
submission, including but not limited to:  
1.    Details of related papers published or submitted for publication. 
 Copies of related papers should be submitted as supplementary data to help the Editor 
decide how to handle the matter.  
2.    Details of previous reviews of the submitted article. 
 The previous Editor's and reviewers' comments should be submitted as supplementary 
data along with your responses to those comments. Editors encourage authors to 
submit these previous communications and doing so may expedite the review process.  
Whether any of the material could be published as data supplements rather than in the print 
version of the article. 
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Title page 
The title page must contain the following information:  
1.    The title.  
2.    The name, postal address, e-mail, telephone and fax numbers of the corresponding 
author.  
3.    The full names, institutions, city and country of all co-authors.  
4.    Up to five keywords or phrases suitable for use in an index (it is recommended to use 
MeSH terms).  
5.    Word count - excluding title page, abstract, references, figures and tables. 
Manuscript format 
The manuscript format must be presented in the following order:  
1.    Title page  
2.    Abstract (or summary for case reports)  
3.    Main text (tables should be in the same format as your article and embedded into the 
document where the table should be cited; images must be uploaded as separate files)  
4.    Acknowledgments, Competing interests, Funding  
5.    Copyright licence statement  
6.    References 
7.    Appendices  
      
Do not use the automatic formatting features of your word processor such as endnotes, 
footnotes, headers, footers, boxes etc.  
 
Provide appropriate headings and subheadings as in the journal. We use the following 
hierarchy: BOLD CAPS, bold lower case, Plain Text, Italics.  
 
Cite illustrations in numerical order (fig 1, fig 2 etc) as they are first mentioned in the text.  
 
Tables should be in the same format as your article and embedded into the document where 
the table should be cited.  
 
Images must not be embedded in the text file but submitted as individual files (view further 
details in File Formats.) 
Filenaming convention 
Where possible, please name your manuscript and image files as shown below. (Please note: 
the manuscript ID # appears at the top of each submission page as soon as you start your 
submission; author refers to the corresponding author's last name.)  
 
1.    Your manuscript file should be named as: yr_manuscript id number_author 
(for example: 2005_001234_clark)  
 
2.    Your image file should be named as: yr_manuscript id number_F# 
(for example: 2005_001234_F1) 
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Statistics 
Statistical analyses must explain the methods used.  
 
Style 
Abbreviations and symbols must be standard and SI units used throughout except for blood 
pressure values which are reported in mm Hg.  
 
Whenever possible, drugs should be given their approved generic name. Where a proprietary 
(brand) name is used, it should begin with a capital letter.  
Acronyms should be used sparingly and fully explained when first used.  
 
 
Figures/illustrations 
Black and white images should be saved and supplied as GIF, TIFF, EPS or JPEG files, at 
a minimum resolution of 300 dpi and an image size of 9 cm across for single column format 
and 18.5 cm for double column format. 
 
Colour images should be saved and supplied as GIF, TIFF, EPS or JPEG files, to a 
minimum resolution of 600 dpi at an image size of 9 cm across for single column format 
and 18.5 cm for double column format. 
 
Images should be mentioned in the text and figure legends should be listed at the end of the 
manuscript.  
 
During submission, when you upload the figure files please label them as Figure 1, Figure 2, 
etc.  The file label will not appear in the pdf but the order in which the figures uploaded 
should be sufficient to link them to the correct figure legend for identification. 
 
We can accept multi-page Powerpoint files. Alternatively, Powerpoint files can be saved as 
JPEG files and submitted as a standard image file.  
Histograms should be presented in a simple, two-dimensional format, with no background 
grid.  
 
Please note: Do not submit colour figures unless you are willing to pay the cost of publishing 
your figures in colour. If you do not wish to pay the colour charges please submit your 
figures in black and white.  
The journal charges authors for the cost of reproducing colour images on all unsolicited 
articles. This charge is heavily subsidised by the journal and covers origination costs only. If 
an image is supplied as a composite figure that contains numerous parts (for example, fig 
1A-D), the image will be considered as a single image, provided that all the parts are supplied 
within a single file that prints out at an overall size no larger that A4 (210 mm x 297 mm). 
The charge for colour processing will be £100 + VAT for the figure. Multi-part colour 
images supplied as separate files will be charged at £100 + VAT for each file. The charge 
only applies to images accepted for print publication and not online only or data supplement 
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files. 
Care should be taken in planning composites because combining different images with 
widely varying colours can lead to contamination or loss of colour and poor quality results. 
When submitting your manuscript, please ensure to include a name and address where the 
invoice should be sent for the colour reproduction costs. If an address is not included, the 
invoice will be sent to the corresponding author. 
 
Unacceptable file formats  
Any file using OLE (Object Linking and Embedding) technology to display information or 
embed files, Bitmap (.bmp), PICT (.pict), Photoshop (.psd), Canvas (.cnv), CorelDRAW 
(.cdr); Excel (.xls); and locked or encrypted PDFs are not acceptable. 
Tables 
Tables should be submitted in the same format as your article and embedded into the 
document where the table should be cited. Please note: Bench>Press cannot accept Excel 
files. If your table(s) are in Excel, copy and paste them into the manuscript file. In extreme 
circumstances, Excel files can be uploaded as supplementary files; however, we advise 
against this as they will not be acceptable if your article is accepted for publication.  
 
Tables should be self-explanatory and the data they contain must not be duplicated in the text 
or figures.  
References 
Authors are responsible for the accuracy of references cited: these should be checked against 
the original documents before the paper is submitted. It is vital that the references are styled 
correctly so that they may be hyperlinked.  
 
In the text  
References must be numbered sequentially as they appear in the text. References cited in 
figures or tables (or in their legends and footnotes) should be numbered according to the 
place in the text where that table or figure is first cited. Reference numbers in the text must be 
given in square brackets immediately after punctuation (with no word spacing) - for example, 
.[6] not [6].  
 
Where more than one reference is cited, separate by a comma - for example, [1, 4, 39]. For 
sequences of consecutive numbers, give the first and last number of the sequence separated 
by a hyphen - for example, [22-25]. References provided in this format are translated during 
the production process to superscript type, which act as hyperlinks from the text to the quoted 
references in electronic forms of the article. 
 
In the reference list  
References must be double spaced (numbered consecutively in the order in which they are 
mentioned in the text) in the [slightly modified] Vancouver style. Only papers published or in 
press should be included in the reference list. (Personal communications or unpublished data 
must be cited in parentheses in the text with the name(s) of the source(s) and the year. 
Authors should get permission from the source to cite unpublished data.) 
 
Punctuation of references must follow the [slightly modified] Vancouver style:  
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12 Surname AB, Surname CD. Article title. Journal abbreviation. Year;Vol:Start page-End 
page.  
 
Use one space only between words up to the year and then no spaces. The journal title should 
be in italic and abbreviated according to the style of Medline. If the journal is not listed in 
Medline then it should be written out in full.  
 
List the names and initials of all authors if there are 3 or fewer; otherwise list the first 3 and 
add et al.  
 
Example references:  
 
Journal 
13 Koziol-Mclain J, Brand D, Morgan D, et al. Measuring injury risk factors: question 
reliability in a statewide sample. Inj Prev 2000;6:148-50.  
 
Chapter in book 
14 Nagin D. General deterrence: a review of the empirical evidence. In: Blumstein A, Cohen 
J, Nagin D, eds. Deterrence and incapacitation: estimating the effects of criminal sanctions on 
crime rates. Washington, DC: National Academy of Sciences 1978:95-139.  
 
Book 
(personal author or authors) (all book references should have specific page numbers) 
15 Howland J. Social norms and drunk driving countermeasures. In Graham JD, ed. 
Preventing automobile injury: new findings from evaluative research. Dover, MA: Auburn 
House Publishing Company 1988:163-96.  
 
Abstract/supplement 
16 Roxburgh J, Cooke RA, Deverall P, et al. Haemodynamic function of the carbomedics 
bileaflet prosthesis [abstract]. Br Heart J 1995;73 (suppl 2):P37.  
 
Electronic citations 
Basically, websites are referenced with their URL and access date, and as much other 
information is given as is available. Access date is important as websites can be updated and 
URLs change. The "date accessed" can be later than the acceptance date of the paper, and it 
can be just the month accessed. See the 9th edition of the AMA Manual of Style for further 
examples. 
 
electronic journal articles: 
Morse SS. Factors in the emergency of infectious diseases. Emerg Infect Dis 1995 Jan-
Mar;1(1). www.cdc.gov/nciod/EID/vol1no1/morse.htm (accessed 5 Jun 1998). 
 
Use as much information as the author gives. The volume/number information in the URL 
will take the user to the start of the individual document; ask the author to supply or confirm. 
Also ask authors to supply the date they accessed the file. 
 
Online First 
Each Online First article has a unique Digital Object Identifier (DOI). This should be 
included in all citations. 
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BEFORE the article has appeared in an issue 
Use the citation format: 
Sabin MA, Ford AL, Holly JMP, Hunt LP, Crowne EC, Shield JPH. Characterisation of 
morbidity in a UK, hospital based, obesity clinic. Arch Dis Child. Published Online First: 24 
October 2005. doi:10.1136/adc.2005.083485 
 
AFTER the article has appeared in an issue 
Use the citation format: 
Sabin MA, Ford AL, Holly JMP, Hunt LP, Crowne EC, Shield JPH. Characterisation of 
morbidity in a UK, hospital based, obesity clinic. Arch Dis Child 2006; 91:126-130 
doi:10.1136/adc.2005.083485 [published Online First: 24 October 2005]. 
 
Electronic Letters 
Author. Title of letter. Journal name Online [eLetter] Date of publication. url 
 
eg: Krishnamoorthy KM, Dash PK. Novel approach to transseptal puncture. Heart Online 
[eLetter] 18 September 2001. http://heart.bmj.com/cgi/eletters/86/5/e11#EL1 
 
 
Digital Object Identifiers (DOIs)  
DOIs are a unique string created to identify a piece of intellectual property in an online 
environment, particularly useful for articles which have been published online before 
appearing in print (therefore the article has not yet been assigned the traditional volume, issue 
and page number reference).  
 
The DOI is a permanent identifier of all versions of an article, whether raw manuscript or 
edited proof, online or in print. Thus the DOI should ideally be included in the citation even 
if you want to cite a print version of an article.  
 
How to cite articles before they have appeared in print 
To cite an electronic article that has not yet appeared in print please use the following citation 
format:  
1. Alwick K, Vronken M, de Mos T, et al. Cardiac risk factors: prospective cohort study. Ann 
Rheum Dis. Published Online First: 5 February 2004. doi:10.1136/ard.2003.001234  
 
How to cite articles once they have appeared in print 
Once the article has been printed the citation should also include the traditional year, volume 
and page numbers, as well as the DOI and original date of publication.  
1. Vole P, Smith H, Brown N, et al. Treatments for malaria: randomised controlled trial. Ann 
Rheum Dis 2003;327:765-8 doi:10.1136/ard.2003.001234 [published Online First: 5 
February 2004].  
 
PLEASE NOTE: RESPONSIBILITY FOR THE ACCURACY AND 
COMPLETENESS OF REFERENCES RESTS ENTIRELY WITH THE AUTHORS. 
Supplementary files 
You may submit supplementary material which may support the submission and review of 
your article. This could include papers in press elsewhere, published articles, appendices, 
video clips, etc. 
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Online only material  
Additional figures and tables, methodology, references, video clips, raw data, etc may be 
published online only to supplement the printed article. If your paper exceeds the word count 
you should consider if any of the article could be published online only as a "data 
supplement". These files will not be copyedited or typeset.  
 
Bench>Press  
All supplementary data files should be uploaded to Bench>Press using the supplementary file 
section. These files are not converted to PDF but will be provided to reviewers and editors in 
the format in which you supply them. 
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Appendix D 
Search Strategy in PsychINFO for ‘carer’ term 
DE "Caregiver Burden" or DE "Caregivers" 
caregiv* OR carer* OR "care giv*"  
caretaker* OR "care tak*" OR children N2 caring OR families N2 caring 
sons N2 care 
sons N2 caring 
daughters N2 care 
daughters N2 caring 
friends N2 care 
friends N2 caring 
grandparen* N2 care 
grandparen* N2 caring 
grandparen* N2 support 
grandparen* N2 supporting 
grandchil* N2 support 
grandchil* N2 supporting 
neighbor*  N2 care 
neighbor*  N2 caring 
neighbor*  N2 support 
neighbor*  N2 supporting 
neighbour*  N2 care 
neighbour*  N2 caring 
neighbour*  N2 support 
neighbour*  N2 supporting 
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relatives N2 care 
relatives N2 caring 
relatives N2 support 
relatives N2 supporting 
parent N2 caring 
parents N2 caring 
mother N2 caring 
mothers N2 caring 
father N2 caring 
fathers N2 caring 
families N2 suppor* 
TX (S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 
or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 
or S28 or S29 or S30 or S31 or S32 or S33 or S34) 
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Appendix E 
Search Strategy in PsychINFO for ‘muscular dystrophy’ term 
TX muscular dystroph* 
TX ―neuromuscular conditions‖ 
TX ―neuromuscular condition‖ 
TX neuromuscular 
TX "neuromuscular disorders" 
TX "neuromuscular disorder" 
TX muscle N3 disease 
S37 or S38 or S39 or S40 or S41 or S42 or S43 
S36 and S44  [combined ‗carer‘ combination and ‗MD‘ combination] 
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Appendix F 
Search Strategy in PsychINFO for ‘psychological distress’ term 
distress 
stress 
pressure 
emotion* N2 pressure 
psychol* N2 pressure 
worry 
strain 
psychol* N2 strain 
emotion* N2 strain 
difficult* 
psychol* N2 difficult* 
emotion* N2 difficult* 
burden 
psychol* N2 burden 
emotion* N2 burden 
mood 
anxiety 
anxiousness 
depress* 
psychol* N2 stress 
psychol* N2 distress 
psychol* N2 tension 
emotion* N2 stress 
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emotion* N2 distress 
emotion* N2 tension 
coping 
psychol* N2 coping 
emotion* N2 coping 
angst 
psychol* N2 angst 
emotion* N2 angst 
anguish 
psychol* N2 anguish 
emotion* N2 anguish 
psychol* N2 reactions 
emotion* N2 reactions 
psychol* N2 responses 
emotion* N2 responses 
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Appendix G – Standardized Data Extraction Sheet 
Study title 
Authors 
Year of publication 
Journal title and reference 
Study Design 
Type of data (Qualitative/Quantitative) 
Quality Score 
Number of participants 
Gender ratio (male:female) 
Participant diagnoses 
Age of participants (mean, standard deviation, range) 
Number of carers interviewed per participant 
Total number of carers interviewed 
Does carer live with the participant (Y/N) 
Carer‘s relationship with the participant 
Age of carers (mean, standard deviation, range) 
Details of data collected (what was measured, interview schedules, which questionnaires) 
Duration of study 
Number of times data collected 
Summary of Method 
 Theoretical perspective 
 Participant recruitment 
Procedure 
Analyses 
 Statistical tests 
 Software used 
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Summary of Results (main findings and statistical significance) 
Summary of discussion/conclusions 
 Main findings 
 Interpretation of findings – links to literature 
 Implications of findings 
 Study limitations 
Where/How paper was obtained 
Notes 
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Appendix H 
Quality Assurance Checklist: Qualitative studies 
(Based on the NICE Guidelines (2009) for assessing qualitative research quality) 
Criteria 
Score 
2 1 0 
Section 1: theoretical approach 
Is a qualitative approach 
appropriate? 
Appropriate 
Not optimally 
appropriate 
Inappropriate 
Is the study clear in what is seeks to 
do? 
Clear Mixed Unclear 
Section 2: study design 
How defensible/rigorous is the 
research design/methodology? 
Defensible 
Partially 
defensible 
Not 
defensible 
Section 3: data collection 
How well was the data collection 
carried out? 
Appropriate 
Partially 
appropriate 
Inappropriate 
Section 4: validity 
Is the role of the researcher clearly 
described? 
Clear Partially clear 
Unclear/Not 
described 
Is the context clearly described? Clear Partially clear 
Unclear/Not 
described 
Were the methods reliable? Reliable Partially reliable Unreliable 
Section 5: analysis 
Is the data analysis sufficiently 
rigorous? 
Rigorous Mixed 
Not 
rigorous/not 
reported 
Are the data ‘rich’? Rich Partially rich Poor 
Is the analysis reliable? Reliable Partially reliable Unreliable 
Are the findings convincing? Convincing 
Partially 
convincing 
Not 
convincing 
Are the findings relevant to the aims 
of the study? 
Relevant Partially relevant Irrelevant 
Are the conclusions adequate? Adequate Partially adequate Inadequate 
Section 6: ethics 
How clear and coherent is the 
reporting of ethical considerations? 
Clear Partially clear Not clear 
Totals    
Total quality score (max. = 28)  
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Appendix I 
Quality Assurance Checklist: Quantitative studies – based on Downs & Black 
(1998) 
Quality Criterion Scoring 
 Yes (1) No (0) 
N/A 
(1) 
Reporting 
1. Is the hypothesis/aim/objective of the study clearly described?    
2. Are the main outcomes to be measured clearly described in the 
Introduction or Methods section? 
   
3. Are the characteristics of the patients included in the study 
clearly described? 
   
4. Are the main findings of the study clearly described?    
5. Are the distributions of principal confounders in each group of 
subjects to be compared clearly described? 
   
6. Does the study provide estimates of the random variability in 
the data for the main outcomes? 
   
7. Have actual probability values been reported (e.g. 0.035 rather 
than <0.05) for the main outcomes except where the probability 
value is less than 0.001? 
   
External validity (generalisability) 
8. Were the subjects asked to participate in the study 
representative of the entire population from which they were 
recruited? 
   
9. Were those subjects who were prepared to participate 
representative of the entire population from which they were 
recruited? 
   
Internal validity – bias 
10. If any of the results of the study were based on ―data 
dredging‖, was this made clear? 
   
11. Were the statistical tests used to assess the main outcomes    
106 
 
appropriate? 
12. Were the main outcome measures used accurate (valid and 
reliable)? 
   
Internal validity - confounding (selection bias) 
13. Were the patients in different intervention groups (trials and 
cohort studies) or were the cases and controls (case-control 
studies) recruited from the same population? 
   
14. Were study subjects in different intervention groups (trials and 
cohort studies) or were the cases and controls (case-control 
studies) recruited over the same period of time? 
   
15. Were study subjects randomised to intervention groups?    
Power 
16. Did the study have sufficient power to detect a clinically 
important effect where the probability value for a difference being 
due to chance is less than 5%? 
   
Totals    
Total Score (max = 16)  
 
 
 
 
 
 
 
 
 
 
Appendix J – Quality Assessment Scores 
Study Name and 
Checklist used 
(Quantitative – QN, 
Qualitative – QV) 
Quality Checklist Item Number 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Total 
Bostrom et al. (2006) 2 2 1 2 2 1 1 2 2 2 2 2 2 1 - - 24 
Dawson & 
Kristjanson (2003) 
2 2 2 1 2 1 2 2 2 2 2 2 2 2 - - 26 
Firth et al. (1983) 2 1 1 1 2 1 2 1 2 1 2 2 2 1 - - 21 
Gagliardi (1991) 2 2 2 2 2 2 1 2 2 2 2 2 1 1 - - 25 
Gravelle (1997) 2 2 2 2 0 1 2 2 2 1 1 1 1 0 - - 22 
Mah et al. (2008a) 1 2 1 1 2 2 2 2 2 2 2 2 2 1 - - 24 
Samson et al. (2009) 2 2 2 2 2 2 1 2 2 2 2 2 2 1 - - 26 
Webb (2008) 2 2 1 2 1 1 1 2 2 1 2 1 2 1 - - 21 
Abi Daoud et al. 
(2004) 
1 1 1 1 0 1 0 1 1 1 1 1 1 0 1 1 13 
Bach et al. (2003) 1 1 0 1 1 1 0 0 1 1 1 1 0 1 1 1 12 
Bothwell et al. (2002) 1 1 0 1 0 0 1 1 1 1 1 0 1 1 1 1 12 
Boyer et al. (2006) 1 1 1 1 0 1 1 0 0 1 1 1 0 1 1 1 12 
Chen et al. (2002) 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 15 
Hatzmann et al. 
(2008) 
1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 14 
Holroyd & Guthrie 
(1986) 
1 1 0 1 1 0 0 1 0 1 1 1 1 1 1 1 12 
Im et al. (2010) 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 14 
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Study Name and 
Checklist used 
(Quantitative – QN, 
Qualitative – QV) 
Quality Checklist Item Number 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Total 
Mah et al. (2008b) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 16 
Nereo et al. (2003) 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 14 
Reid & Renwick 
(2001) 
1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 15 
Thompson et al. 
(1992) 
1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 1 14 
 
 
 
 
 
 
 
 
 
 
 
Appendix K – Instructions for recruitment 
Research Project 
Cognitive profile in advanced Duchenne Muscular Dystrophy (DMD) and the effects of 
hypoventilation on cognition 
Instructions to clinical health care team members recruiting participants 
Inclusion Criteria for Experimental Group 
 Person has a pure DMD diagnosis 
 Person is 16 years or older. 
 Person is a native English speaker. 
 Person is on NIPPV treatment.  
Inclusion Criteria for Control Group 
 Person has a pure DMD diagnosis 
 Person is 16 years or older. 
 Person is a native English speaker. 
 Person is a not candidate for NIPPV treatment anytime within the next 6 months, i.e. 
reports no sleep-related difficulties and experiences no (or very minor) hypoventilation 
problems.  
What do I do when I identify someone suitable?
  
1. Introduce the prospect of participation in research. 
2. Give out the Information Sheet and Consent form and briefly explain what the research is 
about.
  
3. Ask for the patient’s consent for you to pass on their telephone number to Georgia 
Papadopoulou (Researcher), and ask for the best day and time for her to call the patient to 
discuss the project and obtain formal consent if they decide to take part. 
4. If the patient consents, email (G.Papadopoulou@2007.hull.ac.uk) or call Georgia 
(078XXXXXXXX) to pass on the patient‘s details.  
 
 
Thank you! 
For any questions, comments, or issues please contact Georgia on either her email or phone. 
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Appendix L 
Description of the psychometric measures used 
Adult Memory & Information Processing Battery (AMIPB) 
- List Learning: The aim of this subtest is to look at verbal recall performance. It involves the 
verbal presentation of a list of 15 unrelated words to the subject, who then is required to 
recall as many of the words as he/she can, without a time constraint and in any order they 
want. This procedure is repeated five times, providing an opportunity for a learning slope. 
One point is awarded for each correctly recalled word and all the points are summed up at the 
end. A different list is then read out for distraction, and the subject is required to recall as 
many of those words as he/she can. Following this, the subject is then required to recall as 
many words for the original list as possible without the list being read to him/her again. 
- Story Recall: The aim of this subtest is to look at immediate and delayed verbal recall 
performance within a contextual frame of a storyline, presenting a higher load for auditory 
processing. The subject is read a short story about a woman being burgled and is asked to 
reproduce the story at the end of the reading with as much the same words as possible. Points 
awarded range from 0-2 depending on the accuracy of recollection of each section of the 
story. The subject is then asked to remember the story for later re-testing. The story is 
requested from the subject following a series of other irrelevant subtests to investigate longer-
term memory and retention of information. 
Digit Span 
This researcher-created subtest is based on the Wechsler Adult Intelligence Scale (WAIS) 
digit span subtest. It aims to test working memory by verbally presenting the subject with 
strings of random numbers ranging from 1 to 10 which the subject is required to repeat back 
immediately following presentation. The test begins with low demands on working memory 
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by presenting the subject with a string of only 2 numbers. Following successful reproduction 
of at least one of two trials of the string of numbers an additional number is added to the 
string, increasing recall demands. The final string comprises of nine numbers. The subject is 
awarded 1 point for each correct recall with a maximum score of 16. 
Doors and People 
- Doors Test: This subtest measures visual recognition memory. It involves 12 target doors 
presented consecutively for 3 seconds each. The subject is then asked to recognise the target 
doors among three distracters without a time limit. One point is awarded for each correct 
answer. A second set of 12 doors is then presented and the participant is warned that this is 
the harder set to recognise. An identical procedure is followed, giving a maximum possible 
score of 24 points. 
- Names Test: This subtest measures verbal recognition memory. It involves 12 female names 
presented and read out by the participant (to assist encoding and storage via rehearsal). The 
subject is then asked to recognise the target names among three distracters with no time limit. 
One point is awarded for each correct answer. A second set of 12 male and harder names is 
then presented and an identical procedure is followed yielding a maximum possible score of 
24 points. 
Delis-Kaplan Executive Function System (D-KEFS) 
- Colour-Word Interference Test: The subtest explores cognitive flexibility and 
simultaneous processing, and involves four conditions: Naming, Reading, Inhibition, and 
Switching. In the first condition the subject is presented with a page filled with patches of the 
colours red, green, and blue, and he/she is asked to name the colours as quickly as possible. 
In Condition 2 the subject is presented with a page with the words ‗red‘, ‗blue‘, and ‗yellow‘ 
written on it, and is asked to read the words as quickly as possible. In Condition 3 the words 
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are written in a different colour ink to what they actually say and the subject must inhibit 
reading the words and has to name the ink colour instead. Finally, in Condition 4 the subject 
is asked to name the ink colours again but to also switch to reading the word if a word is 
enclosed in a box. Therefore cognitive flexibility is tested both in terms of inhibition as well 
as switching cognitive sets. Response times are recorded and converted to scaled scores.  
- Sorting Test (Recognition): This subtest looks at problem solving and concept formation 
abilities, as well as initiation and cognitive flexibility. The test involves the presentation of 
six different cards that can be grouped into two groups of three cards in each group. The 
examiner groups the cards in different ways and the subject is given 45 seconds to describe 
the rules used to group the cards. Responses receive scores ranging from 0-2 and total scores 
are converted to scaled scores.  
- Twenty Questions Test: This subtest measures logical thinking, hypothesis testing, and 
deduction, as well as category formation. The subject is presented with 30 familiar objects 
and is asked to guess which one the examiner has picked by asking Yes/No questions. The 
subject is asked to try and guess with the fewest number of questions. The number of 
questions and a weighted achievement score are converted to scaled scores, as is the initial 
abstraction score (representing the minimum number of items eliminated by the first question 
asked). 
Ravens Standard Progressive Matrices 
This test of abstract reasoning was used as a measure of general intellectual ability. It requires 
subjects to identify the missing item that completes a pattern, out of six or eight multiple 
choices. The test comprises of five sets of twelve items which become progressively harder. 
A total score is computed from the number of correct responses out of a maximum of sixty. 
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Appendix M 
Patient Information Sheet 
Cognitive profile in advanced Duchenne Muscular Dystrophy (DMD) and the effects of 
hypoventilation on cognition 
Part 1 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take 
time to read the following information carefully. Talk to others about the study if you wish. 
Part 1 tells you the purpose of this study and what will happen if you take part.  
Part 2 gives you more detailed information about the study.  
Ask us if there is anything that is not clear, or if you would like more information.  
What is the purpose of the study? 
The study is looking at patients with DMD over the age of 16 years. We are using some 
questionnaires and tests to look at the ‗thinking‘ or ‗cognitive‘ abilities of this group of 
patients. Examples of cognitive abilities would be your memory and problem solving. This 
will help us understand if these abilities change as you grow up.  
We are also looking at how breathing difficulties during sleep affect your mood, quality of 
life and thinking, and whether treatment for breathing difficulties (called non-invasive 
positive pressure ventilation or NIPPV) helps to improve these areas. 
Why have I been invited? 
Your nurse, physiotherapist, or doctor has referred you for this research because you have a 
diagnosis for DMD and you meet the age criteria to take part. You may also be on a 
ventilation machine to help you with your breathing overnight.  
We are inviting around 40 more patients with DMD over the age of 16 years some of which 
are on a ventilation machine and some of which are not. 
What is ventilation treatment or NIPPV? 
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NIPPV is a machine that helps maintain oxygen levels in your body through use of a simple 
face mask covering your mouth and nose. This is usually used during sleep when breathing 
difficulties occur.  
Patients with DMD often require this treatment, but not everyone will need to start using it at 
the same age or using it to the same extent. This is the reason you may not be aware of the 
treatment at the moment. 
Do I have to take part in the study? 
It is up to you to decide. We will describe the study and go through this information sheet, 
which we will then give to you. If you would like to take part we will ask you to sign a 
consent form, to show you have agreed to take part. You are free to withdraw at any time, 
without giving a reason. This would not affect the standard of care you receive. 
What will happen to me if I take part? 
 Once you agree to take part we will arrange a face-to-face appointment. This can take 
place at your home or hospital whichever is most convenient for you. Before this 
appointment some brief questionnaires will be sent to you by post. They should not take 
you more than 20 minutes to complete. We will ask you to bring these with you to your 
first appointment.  
 The appointment itself will last no longer than 1 ½ hours. During this appointment we 
will be doing some brief tests looking at how well some of your different thinking 
abilities work, for example your memory for seeing things, you memory for hearing 
things, etc. 
Therefore, your involvement with the study will be completing a set of questionnaires and 
having a single appointment.  
What will I have to do? 
All you will need to do is fill out the questionnaires when they are sent to you, and attend the 
arranged appointment (which may be at your home). If you cannot attend please let the 
researcher know.  You will not have to do anything else over and above your normal 
treatment.  
What are the possible disadvantages and risks of taking part? 
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There are no health risks in taking part in this study. The appointment takes place either at 
your home or at the hospital, whichever you prefer.  
We appreciate that everyone‘s time is precious, so the tests we use are generally brief and we 
take regular breaks if and when necessary during the testing to ensure you do not feel tired or 
in discomfort. 
What are the possible benefits of taking part? 
We cannot promise the study will help you personally, but the information we get from this 
study will help improve our understanding of cognitive abilities in people with DMD. This 
will help improve our understanding of DMD and the care we can give to people.   
What happens when the research study stops? 
Your treatment will continue as usual when the study ends. If you have started using 
ventilation treatment this will continue for as long as it is helpful to you, and this decision is 
to be made with your healthcare team. If you were not using ventilation treatment during the 
study and your healthcare team feel this is necessary at any point in the future, treatment will 
be offered as usual. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed. The detailed information on this is given in Part 2. 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled 
in confidence. The details are included in Part 2. 
If the information in Part 1 has interested you and you are considering participation, please 
read the additional information in Part 2 before making any decision. 
Part 2 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the study at any point. If you withdraw from the study we will 
destroy all the data we collected from you. 
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What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (01482 464164). If you remain 
unhappy and wish to complain formally, you can do this through the NHS Complaints 
Procedure (or Private Institution). Details can be obtained from the hospital. 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential, and any information about you which leaves the hospital/surgery will 
have your name and address removed so that you cannot be recognised. We will keep all 
information in a safe, locked place and destroy it at the end of the study. All data use is in line 
with the Data Protection Act and the rules of the NHS.  
What will happen to the results of the research study? 
The findings of the study will be submitted for publication. If you wish to gain access to the 
final report of the results please let us know and we will ensure you receive a copy. No 
participants will be identified in any report/publication. 
Who is organizing and funding the research? 
This research is part of a doctoral degree at the University of Hull. The Humber Mental 
Health Teaching NHS Trust is the sponsor and funder of the research.  
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity. This study has been 
reviewed and given favourable opinion the South Humber Local Research Ethics Committee. 
Who should I contact if I have any questions or concerns after reading this document or 
during the study? - You can contact the researcher (Georgia Papadopoulou) for any 
questions or concerns at 01482 464164. 
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Appendix N 
Centre Number: 1 / 2 / 3 
Patient Identification Number:  
CONSENT FORM  
 
Title of Project: Cognitive profile in advanced Duchenne Muscular Dystrophy (DMD) and the 
effects of non-invasive positive pressure ventilation (NIPPV) on cognition 
Name of Researcher: Georgia Papadopoulou         
                                             
 Please initial 
box 
 
1. I confirm that I have read and understand the information sheet dated 
December 2008 (version 1.5) for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason and without my medical care or legal rights 
being affected.  
 
3. I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by researchers from Hull University, regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records.  
 
4. I agree to take part in the above study.  
 
 
 
 
__________________            ____________           _________________  
Name of Patient                       Date                           Signature  
 
 
 
 
 
__________________             ____________           _________________  
Name of Person                       Date                           Signature  
taking consent  
 
 
 
When completed, 1 copy for patient; 1 for researcher site file; 1 (original) to be kept in medical notes  
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Appendix O 
The documentation relevant to Ethical and R&D approval follows. 
 
